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ABSTRACT 
The triple-negative subtype of breast cancer is etiologically and clinically distinct from the more 
common, less aggressive, and more treatable form of estrogen receptor-positive breast cancer. 
Numerous population-based studies have found that black women are 2 to 3 times more likely to 
develop triple-negative breast cancer than white women. Much of the existing research on racial 
disparities in breast cancer subtype has focused on identifying predisposing biological or genetic 
factors associated with African ancestry. However, this approach ignores growing 
multidisciplinary evidence suggesting that contemporary racial stratification shapes a wide range 
of environmental and social exposures that can subsequently impact cellular physiology and even 
gene expression patterns. Geronimus’ weathering hypothesis provides a unique conceptual 
framework through which to consider how psychosocial and environmental stressors may 
structure the disruption of biological mechanisms according to race. Building upon this 
framework, my dissertation (1) integrates important findings from stress biology, breast cancer 
subtype, and health disparity research in the form of a critical literature review, (2) develops an 
alternative conceptual model for the examination of racial disparities in breast cancer subtype, 
and (3) tests aspects of the model in two empirical analyses, using a combination of state-wide 
cancer registry data, block group-level Census and American Community Survey data, 
individual-level reports of stress and discrimination, and daily cortisol decline, a purported 
biological measure of chronic stress exposure. My findings suggest that there are significant 
associations between neighborhood characteristics (i.e., socioeconomic status and racial 
x 
 
composition) and odds of more aggressive breast cancer subtypes, particularly within highly 
segregated metropolitan areas. However, these associations differ by race/ethnicity and across 
age groups. In a separate study population, the same neighborhood sociodemographic features 
are also associated with significant variation in daily cortisol decline. Taken together, this work 
demonstrates the potential for alternative sociobiological pathways linking race to the risk of 
triple-negative breast cancer, and suggests new avenues for research and public health action. 
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CHAPTER 1 
Introduction 
 
 Breast cancer is the second most common type of cancer diagnosed in American women 
(Carol DeSantis, Siegel, Bandi, & Jemal, 2011). According to National Cancer Institute 
estimates, over 230,000 women will be diagnosed with breast cancer in 2014, and more 
approximately 40,000 women will die of the disease (SEER Cancer Statistics Review, 1975-
2011., 2014). While the overall breast cancer incidence rate remains higher among white women, 
black women of all ages are significantly more likely to die of the disease. The average annual 
age-adjusted breast cancer mortality rate for black women diagnosed between 2003 and 2007 
was 32.4 deaths per 100,000, whereas 23.9 breast cancer related deaths were observed per 
100,000 white women during that same period (Carol DeSantis et al., 2011). This inequality in 
breast cancer-related mortality rates becomes even more striking when considering the fact that, 
until the early 1980’s, breast cancer mortality rates for white and black women were 
approximately equal (Smigal et al., 2006). 
  As with many public health problems, identifying and intervening on the fundamental 
causes of racial disparities in breast cancer mortality has proven to be quite difficult.  Much of 
the research during the past two decades has focused on racial inequalities throughout the breast 
cancer continuum of care (Bigby & Holmes, 2005; Jones & Chilton, 2002; Newman & Martin, 
2007). For example, when compared to white women, black women have lower levels of access 
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to quality mammography services (Hirschman, Whitman, & Ansell, 2007), experience longer 
diagnostic and treatment delays (Gorin, Heck, Cheng, & Smith, 2006; Kerner et al., 2003), and 
are more likely to receive suboptimal care once treatment is initiated (Bradley, Given, & 
Roberts, 2002). However, two studies conducted within the Department of Defense medical 
system indicated that even when white and black women have equal access to free medical care, 
black women still have a higher breast cancer-related mortality rate (Jatoi, Becher, & Leake, 
2003; Wojcik, Spinks, & Optenberg, 1998). A recent review of clinical trial participants at a 
large cancer treatment center found that even when the treatment protocols are standardized and 
prognostic clinical factors are controlled for, black women with breast cancer still fare far worse 
than their white counterparts (Albain, Unger, Crowley, Coltman, & Hershman, 2009). Taken 
together, these finding suggests that unequal access to high-quality health care resources cannot 
fully explain the widening racial inequalities in breast cancer mortality.   
 Racial disparities in several clinical features of breast cancer are also well-documented, 
and are thought to contribute to the observed disparities in survival (Amend, Hicks, & 
Ambrosone, 2006; C. DeSantis, Jemal, & Ward, 2010).  Differences in the distribution of breast 
cancer subtypes among white and black women are particularly intriguing. Numerous studies 
have found that, when comparing black and white breast cancer patients, black women are more 
likely to be diagnosed with tumors that have very low levels of specific hormone receptors 
(Gapstur, Dupuis, Gann, Collila, & Winchester, 1996; Hausauer, Keegan, Chang, & Clarke, 
2007; Joslyn, 2002; Tarone & Chu, 2002). In fact, nearly 25% of black women who were 
diagnosed with breast cancer in California between 1999 and 2003 had tumors that lacked 
estrogen, progesterone, and human epidermal growth factor receptors – commonly referred to as 
triple-negative breast cancer, or TNBC – while less than 11% of white women in the same 
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cancer registry had triple negative tumors (Bauer, Brown, Cress, Parise, & Caggiano, 2007).  
This statistically significant disparity has meaningful clinical implications, as triple negative 
tumors are associated with larger and higher-grade carcinomas at the time of diagnosis and are 
not responsive to current endocrine treatments such as Tamoxifen and Herceptin (Kang, Martel, 
& Harris, 2008; Reis-Filho & Tutt, 2008). As a result, women diagnosed with triple-negative 
tumors have higher rates of five-year cancer-related mortality than women who are diagnosed 
with other types of breast cancer, regardless of the tumor stage at the time of diagnosis (Bauer et 
al., 2007). 
 The highly significant relationship between breast cancer subtype and five-year cancer-
related mortality rate is one reason why breast cancer subtype is a valuable intermediate outcome 
to measure when assessing breast cancer inequalities.  Because breast cancer subtype is thought 
to be determined at the time the tumor begins to develop, observed differences in subtype 
distribution across racial groups should not be influenced by access to breast cancer screening, 
diagnostic, and treatment resources (Morris & Carey, 2007; Perou et al., 2000; Zhu, Bernard, 
Levine, & Williams, 1997). Differences in the population-level distribution of breast cancer 
subtype can therefore be thought of as one of the initial sources of racial inequality in the breast 
cancer experience.  As a result, identifying factors that influence the development of particular 
breast cancer subtypes may be critical to ascertaining upstream interventions that reduce racial 
disparities in breast cancer mortality. 
Race: A Genotypic or Phenotypic Risk Factor? 
Before embarking on research that explicitly explores biologic differences between racial 
groups, one must carefully consider exactly what race means in the context of these studies. For 
the purposes of this proposal, “black” refers to individuals who self-identify with this loosely 
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defined racial/ethnic group.  My discussion of race will center on the social construction of 
majority and minority groups within the American culture, and in no way implies a biological 
basis for this stratification.   
The operationalization of race in prior breast cancer disparities research is much less 
clear.  Historical and cross-cultural perspectives on race (Smedley & Smedley, 2005), as well as 
thoughtful interpretations of the relationship – or lack thereof – between genetic ancestry data 
and race (Cooper, Kaufman, & Ward, 2003) strongly support the position that racial group is 
neither an objective nor biological variable.  Accordingly, several authors explicitly state that 
race is not a biologically meaningful predictor of breast cancer outcomes, and suggest that race 
may be a proxy for other economic or psychosocial factors that are more directly responsible for 
the observed disparities (Brawley, 2002).   However, virtually all research in breast cancer 
disparities has, at best, treated race as simple categorical risk factor.  Some researchers have gone 
a step closer towards making race a biological entity by calling for the identification of inherited 
genetic risk factors that set black women with breast cancer apart from white women affected by 
the same disease (Hayanga & Newman, 2007).  While these researchers may not espouse a 
biological construction of racial groups, their emphasis on searching for inherited risk factors 
that are common only among black women fails to consider the potential effects of the acquired 
biological changes that may result from differential exposure to social and physical environments 
across racial groups.  Given the highly confounded relationships among race, socioeconomic 
position (SEP), and other psychosocial factors in the United States, this omission could be a 
critical mistake.   
 
 
5 
 
Incorporating a Guiding Theoretical Perspective and New Evidence 
 Geronimus has proposed the weathering hypothesis as one mechanism by which 
structural factors may lead to poor health outcomes among minority groups (Geronimus, 1992; 
Geronimus & Thompson, 2004). The weathering hypothesis emphasizes the role of social, 
political, and economic marginalization on health outcomes, particularly among younger black 
women (Geronimus, Hicken, Keene, & Bound, 2006).  This theoretical perspective is 
particularly relevant in the case of racial disparities in breast cancer subtype, as premenopausal 
black women are at a particularly high risk of developing triple negative tumors (Kwan et al., 
2009; Millikan et al., 2008; Parise, Bauer, Brown, & Caggiano, 2009; Trivers et al., 2009). 
An emerging area of research may provide a useful empirical explanation for the 
relationship between the observed racial differences in the distribution of breast cancer subtypes 
and the well-documented differences in the economic and psychosocial experiences of American 
blacks and whites: human stress genomics (S. W. Cole, 2010). Researchers in this field are 
exploring the dynamic regulation of gene expression resulting from interactions with the social 
and physical environment. For example, recent human stress genomics research has 
demonstrated that certain gene expression patterns are associated with stressful experiences in 
the social environment such as social isolation and chronic interpersonal stress (Steven W. Cole, 
2013; S. W. Cole et al., 2007). Human stress genomics research suggests that these sources of 
social stress trigger a series of biological signals that selectively increase or decrease gene 
transcription, particularly among genes involved with inflammatory or immune response systems 
(S. W. Cole, 2009). Transcription is an early and essential step in the process of creating active 
proteins from genes. As a result, alterations in the transcriptional control of a specific gene will 
change the gene’s expression pattern, thereby modifying the amount of protein it produces.  
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Because the breast cancer subtypes are defined by whether or not the tumor expresses 
particular types of proteins, it stands to reason that similar mechanisms of transcriptional control 
may play an important role in the development of specific breast cancer subtype. Recent work by 
Ritter, Antonova, and Mueller (Ritter, Antonova, & Mueller, 2012)  not only supports the 
hypothesized relationship between transcriptional control and breast cancer subtype, but also 
suggests that physiological responses to stress may be an important antecedent. The researchers’ 
in vitro analysis of mouse and human mammary cell lines suggests that dysregulation of the 
stress-mediated cortisol feedback loop reduces the expression of the critical tumor suppressor 
gene, BRCA1.   
To fully appreciate the implications of this finding, some context regarding both BRCA1 
and the stress-medicated cortisol feedback loop is needed. First, mutations in the BRCA1 gene – 
which significantly disrupt the normal expression BRCA1 or the function of its protein – are 
associated with a 50-80% chance of developing female breast cancer by age 70 (Antoniou et al., 
2003; Chen & Parmigiani, 2007). Moreover, roughly 70% of BRCA1 mutation-associated breast 
cancers are classified as triple-negative, whereas only 10-15% of breast cancers diagnoses 
among non-BRCA1 mutation carriers are triple-negative (Atchley et al., 2008; Foulkes, Smith, & 
Reis-Filho, 2010; Mavaddat et al., 2012). There is a growing body of molecular research that 
supports the circumstantial evidence linking decreased BRCA1 expression to increased risk of 
triple-negative breast cancer in particular (see Santarosa & Maestro (2012) for a more detailed 
review).  Second, it is critical to note that the current population-based prevalence estimates for 
heritable BRCA1 mutations among blacks (1.3-1.4%) are roughly half that of non-Ashkenazi 
Jewish whites (2.2-2.9%) (John et al., 2007; Malone et al., 2006). As a result, inherited mutations 
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in BRCA1 are unlikely contributors to the increased prevalence of triple-negative breast cancer 
among black women relative to whites.  
While blacks may have a lower risk of carrying a BRCA1 mutation, they may be at a 
significantly higher risk for exhibiting dysregulation of the stress-mediated cortisol feedback 
loop.  When the cortisol feedback loop is functioning properly, it generates a typical pattern of 
cortisol secretion over a 24-hour period. This pattern, illustrated in Figure 1-1, is often described 
in terms of cortisol levels or changes in levels at certain times of day: the waking cortisol level; 
the change in cortisol from waking to its peak value 30-45 minutes later (the cortisol awaking 
response or CAR); the decrease in cortisol from either the peak or waking level to the bedtime 
level; and the total daily exposure to cortisol, as estimated by the area under the curve.  
Emerging research on population-level variation in diurnal cortisol patterns indicates that U.S. 
blacks and Hispanics from adolescence (A. S. DeSantis et al., 2007)and throughout adulthood 
(Karlamangla, Friedman, Seeman, Stawksi, & Almeida, 2013; Skinner, Shirtcliff, Haggerty, Coe, 
& Catalano, 2011) are more likely to exhibit lower levels of cortisol upon waking, smaller 
cortisol awakening responses, and flatter declines in cortisol levels throughout the day relative to 
whites. These racial/ethnic patterns remain significant even after adjusting for biobehavioral 
factors that are associated with cortisol levels (e.g., smoking, exercise, and obesity) and 
psychosocial characteristics such as cynical hostility, depression, emotional support, and chronic 
burden (A. S. DeSantis et al., 2007; Hajat et al., 2010).  
Due in part to the lack of clear individual-level explanatory factors for the observed 
racial/ethnic variation in diurnal cortisol patterns, researchers have recently turned their attention 
toward neighborhood-level factors (Do et al., 2011; Karb, Elliott, Dowd, & Morenoff, 2012). 
With the long history of race-based residential segregation and the related economic and political 
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marginalization of minorities in this country, it is not surprising that neighborhoods are an 
increasingly common setting for research on the origins of racial/ethnic health disparities. 
However, the fact that different groups live in different areas may not always lead to worse 
social conditions for minority groups. There may very well be advantages for minorities who live 
in neighborhoods with higher percentages of same-minority residents, such as increased access 
to social support, less cultural isolation, and reduced exposure to class- and race-based prejudice 
(Keene & Geronimus, 2011; Pearson & Geronimus, 2011; Pickett & Wilkinson, 2008).  These 
protective effects may be particularly salient in highly concentrated minority neighborhoods 
within metropolitan areas that have high levels of race-based residential segregation, a potential 
manifestation of entrenched racial ideologies (Geronimus, 2000). A nuanced, theory-driven and 
empirically-grounded approach is therefore needed when considering how neighborhood-level 
characteristics may relate to observed racial variation in the dysregulation of the stress-mediated 
cortisol feedback loop. 
Taken together, these emerging lines of research regarding cortisol-related transcriptional 
control of BRCA1 and racial/ethnic variation in observed diurnal cortisol patterns suggest a 
potential alternative mechanism for the origin of racial differences in breast cancer biology.  It is 
therefore plausible that, rather than higher rates of heritable BRCA1 mutations or other less 
penetrant genetic risk factors stemming from shared ancestry, dysregulation of the stress-
mediated cortisol feedback loop could contribute to the significantly higher rates of triple-
negative breast cancers diagnosed among black women via the cumulative impact of decreased 
BRCA1 expression.  
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Dissertation Objectives  
 To begin testing this alternative pathway, I will address the following critical questions in 
three independent yet thematically linked papers: What is currently known – and not known – 
regarding the potential relationship between stress and racial disparities in breast cancer 
subtypes? Among women diagnosed with breast cancer, are neighborhood-level 
sociodemographic characteristics that are empirically or theoretically related to individual-level 
psychosocial stressors also associated with risk of triple-negative tumors? Are neighborhood- 
and/or individual-level stressors associated with a specific biological pathway that may increase 
the risk of developing triple-negative breast cancer?   
 Chapter 2 is a critical review of the empirical and theoretical evidence regarding how 
structural-, neighborhood-, and individual-level stressors may intersect with biological factors to 
contribute to racial disparities in breast cancer subtypes. A new conceptual model linking these 
multilevel factors is included in this paper. The conceptual model is built upon the theoretical 
framework of the weathering hypothesis, and the model serves as the basis for developing the 
empirical analyses proposed for second and third dissertation papers. 
 Chapter 3 focuses on the potential association between race-based residential segregation 
and the observed racial/ethnic variation in the distribution of breast cancer subtypes. As 
introduced here and elaborated upon in the first dissertation paper, exposure to chronic stressors 
within racially and economically segregated residential neighborhoods may contribute to racial 
variation in diurnal cortisol patterns (Do et al., 2011; Friedman, Karlamangla, Almeida, & 
Seeman, 2012; Merkin et al., 2009) and subsequent triple-negative breast cancer risk. Prior work 
by Warner and Gomez (Warner & Gomez, 2010) using California Cancer Registry (CCR) data 
provides an appealing model for exploring potential relationships between residential segregation 
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and breast cancer subtype. In this paper, I use the CCR data and linked California 
Neighborhoods Data System files to examine potential associations between race- and age-
specific distributions of breast cancer subtype and 1) neighborhood-level racial composition, 2) 
neighborhood-level socioeconomic status, and 3) metropolitan-level race-based residential 
segregation.  
 To complement the population-level analysis described above, additional work is needed 
to deepen our understanding of potential neighborhood- and individual-level factors related to 
cortisol dysregulation. In Chapter 4, I use data from the Healthy Environments Partnership Wave 
2 Community Survey and the Race/Ethnicity, Psychosocial and Environmental Stressors, and 
Telomere Length study to look for evidence of diurnal cortisol dysregulation via the average 
daily decline in cortisol levels, as well as associated stressors at the individual and neighborhood 
levels.  I examine whether higher levels of perceived individual-level discrimination, 
neighborhood-level safety stress, and neighborhood-level social environmental stress will each 
independently predict flatter daily declines in cortisol levels after accounting for individual- and 
neighborhood-level sociodemographic characteristics.  
There is little doubt that the fundamental causes of racial inequalities in breast cancer 
outcomes are complex. As Demicheli and colleagues (2007) note, the field is still lacking a 
“unifying hypothesis” that incorporates findings across multiple disciplines. The three proposed 
papers of this dissertation will help fill this gap by integrating diverse stress and breast cancer 
literatures, developing a unifying conceptual model for exploring racial variation in breast cancer 
subtypes, and testing two important components of the model via secondary data analyses. 
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Figure 1-1:  Example of a diurnal cortisol pattern from Dowd, Simanek & Aiello (2009)  
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CHAPTER 2 
Black-White Disparities in Breast Cancer Subtype: The Intersection of Stress & Biology 
 
Introduction 
 Racial disparities in several clinical features of breast cancer are well-documented 
(Amend, Hicks, & Ambrosone, 2006).  However, differences in the distribution of breast cancer 
subtypes among white and black women are particularly troubling. Numerous studies have found 
that, when comparing black and white breast cancer patients, black women are more likely to be 
diagnosed with tumors that have very low levels of specific hormone receptors (Gapstur, Dupuis, 
Gann, Collila, & Winchester, 1996; Hausauer, Keegan, Chang, & Clarke, 2007; Joslyn, 2002; 
Tarone & Chu, 2002). In fact, nearly 25% of black women who were diagnosed with breast 
cancer in California between 1999 and 2003 had tumors that lacked estrogen, progesterone, and 
human epidermal growth factor receptors – commonly referred to as triple-negative tumors – 
while less than 11% of white women in the same cancer registry had triple negative tumors 
(Bauer, Brown, Cress, Parise, & Caggiano, 2007).  A new report based on the National Cancer 
Data Base also found that, regardless of socioeconomic status, black women are nearly twice as 
likely to be diagnosed with triple-negative breast cancer than their non-Hispanic white 
counterparts (Sineshaw et al., 2014).  This statistically significant disparity has meaningful 
clinical implications as triple negative tumors are associated with larger and higher-grade 
carcinomas at the time of diagnosis and are not responsive to current endocrine treatments such 
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as Tamoxifen and Herceptin (Kang, Martel, & Harris, 2008; Reis-Filho & Tutt, 2008). As a 
result, women diagnosed with triple-negative tumors have higher rates of five-year cancer-
related mortality than women who are diagnosed with other types of breast cancer, regardless of 
the tumor stage at the time of diagnosis (Bauer et al., 2007). 
 The highly significant relationship between breast cancer subtype and five-year cancer-
related mortality rate is one reason why breast cancer subtype is a valuable intermediate outcome 
to measure when assessing breast cancer inequalities.  Because breast cancer subtype is thought 
to be determined at the time the tumor begins to develop, observed differences in subtype 
distribution across racial groups should not be influenced by access to breast cancer screening, 
diagnostic, and treatment resources (Morris et al., 2007). Differences in the population-level 
distribution of breast cancer subtype can therefore be thought of as one of the initial sources of 
racial inequality in the breast cancer experience.  As a result, identifying factors that influence 
the development of particular breast cancer subtypes may be critical to ascertaining upstream 
interventions that reduce racial disparities in breast cancer mortality. 
  As with many public health problems, identifying and intervening on the fundamental 
causes of racial disparities in breast cancer mortality has proven to be quite difficult.  Much of 
the research during the past two decades has focused on racial inequalities throughout the breast 
cancer continuum of care (Bigby & Holmes, 2005; Jones & Chilton, 2002; Newman & Martin, 
2007). For example, when compared to white women, black women have lower levels of access 
to quality mammography services (Hirschman, Whitman, & Ansell, 2007), experience longer 
diagnostic and treatment delays (Gorin, Heck, Cheng, & Smith, 2006; Kerner et al., 2003), and 
are more likely to receive suboptimal care once treatment is initiated (Bradley, Given, & 
Roberts, 2002). However, two studies conducted within the Department of Defense medical 
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system indicated that even when white and black women have equal access to free medical care, 
black women still have a higher breast cancer-related mortality rate (Jatoi, Becher, & Leake, 
2003; Wojcik, Spinks, & Optenberg, 1998). A review of clinical trial participants at a large 
cancer treatment center found that even when the treatment protocols are standardized and 
prognostic clinical factors are controlled for, black women with breast cancer still fare far worse 
than their white counterparts (Albain, Unger, Crowley, Coltman, & Hershman, 2009). Taken 
together, these finding suggests that unequal access to high-quality health care resources cannot 
fully explain the widening racial inequalities in breast cancer mortality.  This conclusion further 
emphasizes the need to explore the origins of the observed racial differences in breast cancer 
subtype. 
However, prior to embarking on research that explicitly explores biologic differences 
between racial groups, one must carefully consider exactly what race means in the context of 
these studies. For the purposes of this paper, “black” refers to individuals who self-identify with 
this loosely defined racial/ethnic group.  My discussion of race will center on the social 
construction of majority and minority groups within the American culture, and in no way implies 
a biological basis for this stratification.  But how has race been defined and operationalized in 
previous related research?  Could race be a proxy for other economic or psychosocial factors that 
are more directly responsible for the observed population variation? 
Historical and cross-cultural perspectives on race (Smedley & Smedley, 2005), as well as 
thoughtful interpretations of the relationship – or lack thereof – between genetic ancestry data 
and race (Cooper, Kaufman, & Ward, 2003) strongly support the position that racial group is 
neither an objective nor biological variable.  Several authors explicitly state that race is not a 
biologically meaningful predictor of breast cancer outcomes (Brawley, 2002).   However, other 
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researchers call for the identification of inherited genetic risk factors that set black women with 
breast cancer apart from white women affected by the same disease (Hayanga & Newman, 
2007).  While these authors may not espouse a biological construction of racial groups, their 
emphasis on searching for heritable risk factors that are common among black women fails to 
consider the potential effects of the acquired biological changes that may result from differential 
exposure to social and physical environments across racial groups.  Given the highly confounded 
relationships among race, socioeconomic position (SEP), and other psychosocial factors in the 
United States, this omission could be a crucial mistake.   
 Geronimus has proposed the weathering hypothesis as one mechanism by which 
structural factors may lead to poor health outcomes among minority groups (Geronimus, 1992; 
Geronimus & Thompson, 2004). The weathering hypothesis emphasizes the role of social, 
political, and economic marginalization on health outcomes, particularly among younger black 
women (Geronimus, Hicken, Keene, & Bound, 2006).  This theoretical perspective is 
particularly relevant in the case of racial disparities in breast cancer subtype, as premenopausal 
black women are at a particularly high risk of developing triple negative tumors (Kwan et al., 
2009; Millikan et al., 2008; Parise, Bauer, Brown, & Caggiano, 2009; Trivers et al., 2009). 
 Two emerging areas of basic science research may provide a useful empirical 
explanation for the relationship between the observed racial differences in the distribution of 
breast cancer subtypes and the well-documented differences in the economic and psychosocial 
experiences of American blacks and whites: epigenetics and human stress genomics. Researchers 
from both fields are exploring the dynamic regulation of gene expression resulting from 
interactions with the social and physical environment, but via different molecular mechanisms.  
Epigenetic mechanisms have been described as “lying above the genome,” in that they are not 
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necessarily heritable changes that are passed on from generation to generation, but they play a 
significant role in determining what proteins are made in specific cells under specific conditions 
(Berger, Kouzarides, Shiekhattar, & Shilatifard, 2009). In addition, recent human stress 
genomics research has demonstrated that certain gene expression patterns are associated with 
stressful experiences in the social environment such as social isolation (Cole et al., 2007; Sloan 
et al., 2010; Szyf, McGowan, & Meaney, 2008). Because the breast cancer subtypes are defined 
by whether or not the tumor expresses particular types of proteins, it stands to reason that 
epigenetic and other forms of transcriptional control play an important role in the determination 
of breast cancer subtype. Taken together, these two lines of research suggest a potential 
alternative mechanism for the generation of racial differences in breast cancer biology, and thus, 
mortality. 
This paper will examine seminal findings in each of these disciplines and identify the 
limitations of the current literature. The weathering hypothesis and broader stress process theory 
serve as the theoretical basis for integrating epigenetic concepts into a novel interdisciplinary 
hypothesis. By using a multilevel, theory-based approach to examine the observed racial 
disparities in breast cancer mortality, I hope to identify new avenues for research and 
intervention that may also be relevant to other racial/ethnic health disparities.   
 
 
Black-White Disparities in Breast Cancer Subtype 
Breast cancer is now widely recognized as a highly heterogeneous disease. Among the 
first supporting pieces of molecular evidence came in the early 1970’s when McGuire reported 
that some breast carcinomas have estrogen receptors (and are thus referred to as ER-positive 
cancers), while other, ER-negative breast cancers do not (McGuire, 1973). Since that initial 
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report, estrogen receptor status has been found to play an important role in the treatment and 
natural history of breast cancer.  Not only are ER-negative cancers non-responsive to standard 
endocrine treatments such as tamoxifen, but they are also more likely to be diagnosed in pre-
menopausal women, are associated with larger and higher-grade carcinomas at the time of 
diagnosis, and have a worse prognosis (W. Y. Chen & Colditz, 2007; Thorpe, 1988).   
More recent research in the area of breast cancer hormone receptors has identified two 
additional receptors that have important clinical and prognostic implications: progesterone 
receptor (PR) and human epidermal growth factor receptor 2 (HER2).  Tumors that express little 
to no ER, PR, or HER2 are commonly referred to as triple-negative tumors. Despite the prolific 
use of this term since inception 4 years ago, there are still no firm diagnostic guidelines as to 
exactly how little hormone receptor expression is needed in order to qualify as a triple-negative 
tumor (Foulkes, Smith, & Reis-Filho, 2010). Even with the heterogeneous application of the 
triple-negative categorization, studies have consistently found that approximately 15% of all 
invasive breast tumors fall into this category, and that they have many of the same clinically 
aggressive characteristics as ER-negative tumors (Foulkes et al., 2010). 
The advent of DNA microarray technology has enabled scientists to rapidly examine the 
expression pattern of hundreds of genes – including the ER, PR, and HER2 genes – 
simultaneously.  Investigations conducted in several different countries have identified at least 
four common sets of gene expression patterns, and therefore, four molecular subtypes of breast 
cancer (Carey et al., 2006; Perou et al., 2000; Sorlie et al., 2003). The most common molecular 
subtype, luminal A, expresses the estrogen receptor gene and thus is ER-positive.  Basal-like 
breast cancers are the second most common subtype, and the estrogen receptor gene is not 
typically expressed in this group of carcinomas. As is the case with triple-negative tumors, basal-
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like breast cancers are associated with more aggressive carcinoma progression and worse overall 
prognosis (Carey et al., 2006).  
 Triple-negative and basal-like subtypes of breast cancer are related in that they are both 
are largely defined by their ER-negative status. (Nielsen et al., 2004) However, several studies 
indicate that these categories are not completely equivalent on a biological or clinical basis.  
Figure 2-1 summarizes the current literature regarding the overlap and distinction between triple-
negative and basal-like subtypes (S. Badve et al.; Bertucci et al., 2008; Linn & Van 't Veer, 
2009; Olopade, Grushko, Nanda, & Huo, 2008; Perou, 2010; Schneider et al., 2008).  
 Despite incomplete concordance between triple-negative and basal-like subtypes, these 
two terms are sometimes used interchangeably in the literature. Strictly speaking, basal-like 
breast cancers are diagnosed using DNA microarray analysis to detect the complex gene 
expression patterns.  However, several studies define the breast cancer molecular subgroups by 
the results from standard immunohistochemical (IHC) procedures: tumors that are ER-negative 
and PR-negative but also express cytokeratins (e.g., CK5/6) and may or may not express HER2 
are deemed “basal-like” (Dunn, Agurs-Collins, Browne, Lubet, & Johnson, 2010). This 
technique circumvents the financial challenges of using the DNA-based methods of tumor 
categorization in large studies and produced accurate results in a sample of 21 genetically-
identified tumors, but raises questions as to whether this may be yet another, subtly different 
breast cancer subgroup. (Nielsen et al., 2004) In addition, IHC testing algorithms were only 
recently standardized (Hammond et al., 2010). Earlier studies of repeated IHC testing across labs 
yielded different IHC results in up to 20% of the cases (S. S. Badve et al., 2008; Regan et al., 
2006), which is indicative of considerable limitations in the breast cancer subtype literature 
(Foulkes et al., 2010). 
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While the classification criteria of ER- tumors, triple-negative tumors, and basal-like 
tumors varies, there is substantial evidence that black women diagnosed with breast cancer are 
more likely to have the more aggressive subtype, regardless of how that subtype is defined.  
Table 2-1 summarizes some of the largest and most recent studies of the distribution of breast 
cancer subtype among black and white women diagnosed with breast cancer.  Among the papers 
that reported race-specific odds, black women were nearly 2 to 3 times more likely to be 
diagnosed with the aggressive breast cancer subtype under study. (Bauer et al., 2007; Carey et 
al., 2006; Gapstur et al., 1996; Parise et al., 2009; Stead et al., 2009; Trivers et al., 2009) 
Recent epidemiological studies summarized in Tables 2-2 through 2-4 have identified 
additional factors that increase women’s chances of developing more aggressive subtypes of 
breast cancer.  The body of research has focused on the triple-negative subtype as the outcome of 
interest, primarily due to the relative ease of obtaining ER, PR, and HER2 receptor status data 
from cancer registries and medical records. While the cost of DNA microarray technology is 
falling, use of molecular profiling is not currently well-integrated into routine clinical care 
(Weigelt, Pusztai, Ashworth, & Reis-Filho, 2012). 
 The data presented in these tables and in the epidemiology of breast cancer subtype 
literature point to three important issues.  First, the selection of an appropriate comparison group 
has differed across studies.  To identify true causal risk factors, one would ideally need to follow 
a large population who is susceptible to the disease of interest, monitor each individual’s level of 
exposure to suspected risk-increasing and risk-reducing factors, and then see who develops the 
disease over the course of the vulnerability period.  This is certainly not a feasible 
methodological approach with complex diseases that may manifest at virtually any point in 
adulthood, as is the case with breast cancer. The majority of epidemiological studies in general 
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as well as those summarized in Tables 2-2 through 2-4 use a case-only approach and compare 
triple-negative or IHC defined basal-like cases to all other breast cancer cases diagnosed in the 
population of interest.  Using this approach allows for risk factors that differ across breast cancer 
subtypes in either their magnitude or direction to be interpreted as indicators of etiologic 
heterogeneity (Troester & Swift-Scanlan, 2009). Results generated using case-only comparisons 
therefore cannot speak to overall, lifetime risk of developing specific breast cancer subtypes.  
This is an important distinction, particularly when considering population-level dissemination 
and interpretation of results.  
Taking this case-only approach has revealed some significant differences when 
comparing triple-negative risk factors to those for breast cancers that are ER-positive.  The most 
consistently significant factors associated with increased incidence of aggressive breast cancer 
subtypes have been black race and younger age of onset (Bauer et al., 2007; Carey et al., 2006; 
Gapstur et al., 1996; Kwan et al., 2009; Millikan et al., 2008; Parise et al., 2009; Setiawan et al., 
2009; Trivers et al., 2009). Given that these factors reflect demographic features rather than a 
direct causal link to breast cancer subtype, analyses of biologically plausible risk factors are 
generally adjusted for both race and age (see footnotes following Table 2-4 for study-specific 
adjustments). Evidence for these biologically plausible risk factors is decidedly mixed. Some of 
the more interesting results highlighted in Table 2-3 are associations between aggressive breast 
cancer subtype, younger age at first birth, and greater number of live births. (Millikan et al., 
2008; Trivers et al., 2009)  These findings counter the widely held notion that the reduction in 
lifetime estrogen exposure afforded by having a first live birth before age 30 and/or more than 
one full-term pregnancy lowers one’s overall breast cancer risk.   
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Little attention has been paid to the possibility that these less intuitive risk factors for 
aggressive breast cancer subtypes may be related to their social patterning across racial/ethnic 
groups. For example, 23.1% of black women who gave birth in 1990 were teenagers, while 
teenage mothers made up only 10.9% of all white women who gave birth that year (Bureau, 
2009).  It is possible that the relationship between aggressive breast cancer subtype and age at 
first birth is confounded by other unidentified exposures that may increase both black women’s 
likelihood of giving birth at a younger age and their likelihood of developing an aggressive 
breast tumor. Previous research indicates that there may be advantages for black women to give 
birth at younger ages, as black women experience a faster and steeper health decline in later 
childbearing years (Geronimus, 1994; Geronimus & Korenman, 1993).  Socially, there are 
additional benefits to having children earlier in life, such as the increased availability and better 
health of grandparents and other child care providers from older generations (Delaire & Kalil, 
2002).  This type of support may be particularly important to women who reside in low income 
neighborhoods and/or who do not currently have a committed partner to assist with child rearing 
and help provide financial support.  As described later in this paper, these and other sources of 
social stress may also have an impact on the development of aggressive breast cancer subtypes. 
However, it is important to note that the racial difference in percentage of births to teenage 
mothers is shrinking, as teenage births represented 17.0% of all births to black women in 2007 
and 9.4% of births to white women (U.S. Census Bureau, 2009).  How this demographic shift 
may impact racial differences in aggressive breast cancer incidence rates remains to be seen. 
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Critical Analysis of Stark, et al (2010) 
The conflation of race, biology, and social factors is not unique to breast cancer 
epidemiology, but it appears to be particularly pervasive in this literature.  A study published this 
month in the highly-cited journal Cancer boldly suggests that the increased risk of triple-
negative breast cancer observed among black American women is related to their shared genetic 
ancestry with “Ghanaian/African” women (Stark et al., 2010).  The opening argument for such a 
link is that because 1) triple-negative breast cancers share some clinical similarities with breast 
tumors found in BRCA-1 and 2) black women are more likely to develop triple-negative breast 
cancer, there may be a genetic predisposition for this subtype that is more common among 
women of African ancestry.  The authors present findings that, among white American, black 
American, and Ghanaian women diagnosed with advanced stage, poorly differentiated grade 
breast cancer, the percentage of triple-negative tumors were 15.4%, 41.9%, and 83.3%, 
respectively.  
The authors admit that their results are limited by the fact that all of the Ghanaian breast 
cancer cases were diagnosed while palpated upon clinical examination and acknowledge that the 
average age at diagnosis was 12 to 14 years younger than American black and white women, 
respectively.  This data combined with the fact that the average life expectancy of Ghanaian 
women is about 20 years less than that of American women and the afore mentioned younger age 
distribution of triple-negative breast cancer in the United States presents the possibility that the 
Ghanaian cases described in this study are either 1) not representative of the full range of breast 
cancer cases in Ghana, many of which may be slower growing, later presenting ER-positive 
tumors, or 2) Ghanaian women may be less likely to be diagnosed with later-onset ER-positive 
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tumors by virtue of the population’s age structure rather than any genetic susceptibility to ER-
negative disease. 
While the work of Stark, et al, is certainly provocative, it suffers from several additional 
limitations that are pervasive in the breast cancer subtype disparities literature.  First and 
foremost, the authors make a very broad and dubious assumption about the relationships among 
race, ancestry, and genetics.   For their hypothesis to be true, the phenotype of skin color – and 
the racial categorization that comes along with it – must be an accurate, objective marker of a 
shared genetic ancestry. However, it is clear that race is neither objective nor biological data to 
begin with.  Evidence for this claim can be found in historical and cross-cultural perspectives on 
race (Smedley & Smedley, 2005), as well as thoughtful interpretations of the relationship – or 
lack thereof – between genetic ancestry data and race (Cooper et al., 2003). Moreover, work by 
Parra, Kittles, and Shriver (2004) demonstrated that the correlation between skin color and 
ancestry informative genetic markers is highly variable across populations. Given this data and 
the history of racial/ethnic stratification in the United States, researchers should use caution 
when assuming that observed race/ethnicity is a strong indicator of ancestry-associated genetic 
risk. 
While Stark and colleagues may not espouse a biological construction of racial/ethnic 
groups, their emphasis on searching for heritable risk factors that are theoretically more 
prevalent among black women fails to consider the potential effects of the acquired biological 
changes that may result from differential exposure to social and physical environments across 
racial groups.  One major source of differential social and physical environmental exposures 
across racial groups, particularly in the United States, is poverty. White-black differences in most 
domains of socioeconomic position (SEP) are well documented (T. LaVeist, 2005). However, 
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Stark, et al (2010) dismisses any notion that race could be confounded by the effects of poverty 
with the following statement:  
 “Data from international registries (in countries that have more homogeneous 
populations and therefore less opportunity for confounding between race/ethnicity and 
socioeconomic factors) fail to show any consistent association between poverty and 
frequency of ER-negative breast cancer.”                                                               p. 4931 
 
There are numerous flaws with this contention. First, the measurement of SEP in breast 
cancer registries is rudimentary at best (Baquet & Commiskey, 2000). Given the complex 
relationship between racial group and SEP that is shaped by the structural and community-level 
factors (D. R. Williams & Collins, 2001), careful attention must be paid to how these individual-
level sociodemographic constructs are defined and measured in studies of breast cancer 
outcomes.  Most studies of breast cancer incidence and mortality use data from large population-
based samples, such as the National Cancer Institute’s Surveillance, Epidemiology, and End 
Results (SEER) registry.  These local, state, and national tumor registries contain useful 
information on breast cancer subtype, tumor stage, and pathology, but they typically do not 
include any direct measures of individual-level SEP (Koh, Judge, Ferrer, & Gershman, 2005).  
To compensate for this lack of data, investigators frequently use small area measures (e.g., 
census tract-level median income) as proxies for the unavailable individual sociodemographic 
data (for one such example, see (Simon et al., 2006). However, this type of proxy approach to 
measuring SEP is not a methodological sound approach. Geronimus and Bound (1998, p.485) 
caution that, “… aggregate measures tap a more global construct than do microlevel measures 
and should not be interpreted as equivalent to microlevel constructs.” Despite the widespread use 
of aggregate SEP measures in the breast cancer disparities literature, very few investigators have 
interpreted their findings in terms of a “more global construct.”  
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Even if the current measures of SEP were robust, the authors specifically cite studies 
from foreign countries with more racially homogenous populations.  What the authors fail to 
mention is that each of the countries cited are European nations with strong social welfare 
programs. As a result, having a lower SEP may not have the same degree of health and welfare 
implications as it does in the United States. Moreover, the authors imply that the racial 
homogeneity of these nations effectively controls for the non-genetic sources of variation in risk 
for aggressive breast cancer subtypes.  Many studies have shown that the physical and mental 
health benefits of increasing SEP are not as robust among blacks as they are among whites in the 
United States (D. R. Williams, Mohammed, Leavell, & Collins, 2010). These findings strongly 
suggest that, at least in the United States, there are interactive effects between race and SEP. 
Simply looking at the association between breast cancer subtypes and SEP of the majority or 
dominant race in a nation fails to capture the full effect of that interaction.  Finally, the authors 
fail to acknowledge that there are in fact several domestic studies of SEP and risk of aggressive 
breast cancer subtypes that have found significantly higher rates of aggressive disease among 
poor American women (Bauer et al., 2007; Gordon, 1995; A. Taylor & Cheng, 2003; Vona-
Davis et al., 2008). 
 The rapidly expanding body of literature on aggressive breast cancer subtypes, their 
population distribution, and their associated risk factors has established that, among women 
diagnosed with breast cancer, black women are more likely than whites to have this more severe 
form of disease.  What remains subject to much debate is why this is the case. Investigations into 
the role of African ancestry in breast cancer subtype are being pursued by Stark and colleagues 
as well as by prominent researchers from other institutions (Garner et al., 2008; Huo et al., 
2009). By taking this genetic ancestry approach, these researchers are neglecting the fact that 
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race is a social construction.  Skin color is a phenotype that may give some indication as to 
where one’s ancestors lived prior to coming to the United States.  However, skin color most 
certainly also has significant implications for the ways in which individuals are perceived and 
interact within other individuals and institutions during the course of their day-to-day lives.  
With recent advances in stress biology and a better understanding of its roles in health and 
disease, it is important that future research regarding breast cancer subtype consider the potential 
social origins of black-white disparities as well.  
 The following section will review the existing literature on the relationship between 
stress and breast cancer, with a focus on breast cancer incidence and development of metastatic 
disease.  I will then introduce the theoretical basis for a new conceptual model that captures 
potential role of stress in the development and/or progression of the basal-like breast cancer 
subtype. Next, I will introduce recent evidence regarding the potential biological pathways from 
perceived stress to basal-like breast cancer relevant biological systems.  The concluding section 
will focus on sources of stress that, on a population level, differ between black and white 
women.  I will focus on neighborhood-level factors in particular, and offer suggestions for future 
areas of research and their broader health disparities and social policy implications. 
 
Previous Investigations of the Relationship between Stress & Breast Cancer Risk 
The theoretical and empirical relationship between stress and various health outcomes 
has been well documented, and the investigation of stress as a risk factor for breast cancer is also 
not a new proposition (Hill, Ross, & Angel, 2005; Pearlin, Schieman, Fazio, & Meersman, 2005; 
Wheaton, 1985).  However, previous studies investigating the potential link between various 
types of psychosocial stressors and breast cancer risk have been underwhelming both in terms of 
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their methodology and the strength of their findings. From the 1960’s onward, numerous studies 
tested this proposed relationship and reported conflicting results.  Three meta-analyses published 
in 1999 and 2000 attempted to summarize and interpret the conflicting literature (Butow et al., 
2000; McKenna, Zevon, Corn, & Rounds, 1999; Petticrew, Fraser, & Regan, 1999). Petticrew, et 
al, conducted the most rigorous analysis, which included a well-described method for evaluating 
the quality of the studies as well as their collective results.  
 Petticrew and colleagues identified 29 studies conducted between 1966 and 1997 that met 
their inclusion criteria for analysis.  Of the 29 studies, only one was a prospective study, 14 were 
limited prospective studies in that the participants were surveyed after a breast lesion was 
discovered but prior to receiving a biopsy and diagnosis, and the remaining 14 studies were case-
control trials.  Case-control studies have methodological limitations in and of themselves, but 
they can be particularly problematic in stress research due to the fact that a case is, by definition, 
already affected by the outcome of interest, which may create a greater opportunity for recall 
bias when reporting previous stressful events.  The limited prospective design may not be much 
better, as the participants may already know more about their health status than that investigator 
is aware of at the time of the survey.   
 Twelve of the 29 studies, including the prospective study, operationalized stress as 
bereavement, most commonly related to the loss of a husband.  Only three of the 12 studies 
reported a statistically significant result that supported the hypothesis that stress in the form of 
bereavement was associated with an increased risk of developing breast cancer.   All 28 of the 
limited-prospective and case-control studies evaluated the relationship between other types of 
stressors, including divorce (Kvikstad, Vatten, Tretli, & Kvinnsland, 1994), disturbing war 
experiences (Scherg, 1987), and threatening events (C. C. Chen et al., 1995).  Only twelve of the 
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28 studies reported a statistically significant association between their specified non-bereavement 
stress and breast cancer risk.   
 More recently, Chida, et al (2008) completed a meta-analysis of 83 prospective breast 
cancer studies that examined associations between stress-related psychosocial factors and cancer 
incidence, cancer-specific survival, and cancer mortality within community-based populations. 
While no association was seen between the psychosocial factors (e.g., stressors, stress-prone 
personality or poor coping style, poor social support, emotional distress or poor quality of life) 
and community-based breast cancer incidence or mortality, there was a significant negative 
relationship with breast cancer-specific survival (combined hazard ration 1.13, 95% CI = 1.05-
1.21). (Chida, Hamer, Wardle, & Steptoe, 2008) 
 Some of the variation in both the individual studies’ and the meta analyses’ results may 
be attributed to limitations of common stress measurement approaches. Many of the studies used 
checklists such as the Social Readjustment Rating Scale created by Holmes and Rahe (1967). 
The use of such checklists presents several measurement issues, including the lack of event 
severity ratings and other contextual information about the events and the respondent. These are 
critical pieces of information, as being exposed to a stressor may not elicit distress, nor the same 
degree of distress, in every individual. Individual-level response to certain types of stressors may 
be dependent upon multiple exogenous factors such as baseline emotional resiliency, 
socioeconomic position, or the type and amount of available social support (Brown, Meadows, & 
Elder, 2007). The basic stress checklist approach also does not account for the fact that multiple 
events to be interrelated (ie., going through a divorce and experiencing a major change in 
financial state) and perhaps multiplicative in their effects, rather than simply additive.  Similarly, 
some of the items on the checklist could actually occur as a result of experiencing the health 
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outcome under study, making interpretation of positive associations difficult to interpret.  As 
discussed earlier, the latter issue is particularly problematic in case-control study designs.  
 In addition to concerns regarding the manner in which the many different types of stress 
were assessed, each of the reviewed studies varied widely in terms of the timeframe during 
which stress was measured.  Some of the studies only asked participants to report stressful events 
that occurred within the past year, whereas other studies asked about stress over the course of the 
participants’ lifetime.  As with other late-onset, complex diseases, it is unclear how long an 
individual would need to be exposed to any one or more risk factors prior to developing breast 
cancer, thereby making it difficult to determine what the appropriate reporting timeframe should 
be. 
 Another methodological problem observed in several of the studies is the lack of 
adjustment for known breast cancer risk factors. For example, Cheang and Cooper’s (1985) 
limited-prospective study found that the women who were diagnosed with breast cancer reported 
significantly more stressful life events and life events than the women who were diagnosed 
benign breast disease or who were healthy controls. However, they did not adjust for any 
confounders or baseline demographic variation.  As a result, the cases in this study were, on 
average, 2.5 years older than the women in the benign breast disease group and 7.5 years older 
than the healthy controls.  Not only do general risks for developing breast cancer increase with 
age, but with increasing years of life, one is also more likely to experience additional life events 
and stressful life event.  Due to the high potential for confounding, these results should be taken 
with great caution. 
While more recent studies have taken into account other breast cancer risk factors, 
virtually all of the existing stress-related research studies have treated breast cancer risk as a 
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single, uniform entity. With the relatively recent establishment of breast cancer subtypes, it has 
become quite clear that breast cancer is a heterogeneous set of conditions with distinct risk 
factors, etiologies, molecular signatures, natural histories (Sorlie, 2004).  This heterogeneity has 
not been accounted for in the stress and breast cancer risk literature, as none of the studies in the 
four meta analyses described above stratified their cases by breast cancer subtype. This lack of 
subtype specificity may be a major contributor to the largely equivocal results, as the effects of 
stress on breast cancer subtypes may very well be different given the known effects of stress on 
the endocrine system.  For example, chronic psychosocial stress can lead to disruption of the 
hypothalamic-pituitary-gonadal (HPG) axis, which in turn lowers the level of endogenous 
estrogen production (Chrousos, Torpy, & Gold, 1998).  As a result, risk for ER-positive tumors 
could actually be reduced among individuals exposed to chronic stress, while ER-negative tumor 
risk may be unaffected or even increased via other stress-related neuroendocrine or telomere 
length pathways. 
One recent randomized trial of an intensive group therapy intervention among women 
diagnosed with metastatic breast cancer did stratify the results by ER status, and provides the 
first empirical justification for stratifying by breast cancer subtype. Spiegel and colleagues 
(2007) found that the ER-negative women randomized to the experimental arm survived a 
median of 29 months compared to only 3 months in the control group, who received only 
educational materials.  There was no significant difference in survival between ER-positive 
women randomized to the intervention or the control arm. While the intervention did not 
measure stress levels directly, the findings imply that reducing stress via intensive therapy has 
greater survival benefits for women with a more aggressive breast cancer subtype.  This finding 
supports the hypothesis put forth by Chida, et al (2008) in that there may be several direct 
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physiological pathways that may link psychosocial stress to cancer survival, including: impaired 
DNA repair mechanisms, promotion of tumor migration and infiltration via changes in glucose 
uptake rates, and increased tumor vascularization. A more detailed account of these biological 
pathways as well as mouse model evidence to support the role of stress in activating these breast 
cancer-specific effects will be presented in the review of the conceptual model below. 
Finally, another thought-provoking finding was cited in a recent analysis of stress and 
breast cancer incidence among participants in the Women’s Health Initiative (Michael et al., 
2009).  Overall, the authors found that increased stress was associated with lower risk of post-
menopausal breast cancer. However, participant reports of one “severely stressful life event” 
were associated with a small (but not statistically significant) increase in breast cancer risk only 
among black women. Melhem-Bertrandt & Conzen (2010) suggest that the theorized differential 
effects of stress on breast cancer subtype risk should be considered in addition to the “underlying 
population-based differences” in subtype risk (p. 133).  Perhaps a better question may be whether 
the population-level differences in breast cancer subtype reflect population-level differences in 
exposure to – and physiological consequences of – chronic and severe stress. 
 
An Alternative Hypothesis & Conceptual Model 
 Based on the literature reviewed thus far, an intriguing portrait of racial disparities in 
breast cancer subtype emerges. Relative to whites, black women are approximately 2 to 3 times 
more likely to develop a more aggressive subtype of breast cancer, no matter how that subtype is 
defined.  This subtype, which will be referred to as basal-like breast cancer or BLBC for the 
duration of this paper, is clinically, epidemiologically, and molecularly distinct from the most 
common form of breast cancer, luminal A.  These distinctions have not been accounted for in the 
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vast majority of prior research regarding the relationship between stress and breast cancer 
incidence and mortality.  Similarly, racial differences in the exposure to stressors and the 
availability of coping resources have not been taken into account in the field of breast cancer 
health disparity research.  In fact, much of the research as to why black women have 
significantly a higher rate of BLBC has focused upon possible genetic factors related to their 
African ancestry.  Rather than continuing this overly simplistic search for risk factors in black 
women’s genotype, I am proposing an alternative model that explores the implications of the 
phenotype of being black in America, particularly in regard to exposure to chronic stressors and 
strains.  The following description of the conceptual model (Figure 3-2) will briefly introduce 
structural- and community-level factors that may serve as important sources of racial variation in 
exposure to key stressors and coping resources. The remainder of the model and this paper will 
focus largely on the individual-level factors, including a general overview of the three potential 
biological pathways that may connect stress to the incidence and progression of basal-like breast 
cancer. 
 The weathering hypothesis (Geronimus, 1992, 2001) provides the overall framework for 
translating structural- and community-level variables into the individual-level factors that are 
proximal to breast cancer subtype. The weathering hypothesis suggests that the cumulative 
impact of social and economic exclusion throughout the life course places individuals – 
especially black women – at a significantly increased risk of poor health outcomes, particularly 
in early and middle adulthood (Geronimus, 2001).  This framework is especially appropriate 
given that the outcome of interest, incidence of the basal-like breast cancer subtype, occurs more 
frequently in pre-menopausal black women than in any other demographic group (Carey et al., 
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2006).  Aspects of Jackson and Knight’s (2006) model of coping behaviors will also be included, 
as well as more general themes from Stokols’ (1992) social ecological perspective.
 
Structural-level Factors 
 Structural-level factors are the broadest level of factors included in Stokols’ (1992)  
social ecological perspective. In order to better understand and address the root causes of health 
disparities, these relevant structural factors must be taken into consideration (Link & Phelan, 
1995).  The proposed conceptual model focuses on historical and current political and economic 
inequalities as antecedent variables affecting breast cancer subtype.  
 Political and economic inequalities have had a strong influence on the residential patterns 
of many minority groups within the United States. Massey & Denton (1993) present a classic 
narrative on the origins of racial segregation and the urban ghetto in particular.  According to the 
authors, some southern cities during the early 1900’s created or reinforced race-based residential 
segregation patterns by passing ordinances that legally defined areas were white and black 
people could live. The authors also describe more subtle but equally effective tactics such as 
blockbusting, which decreased neighborhood property values, increased the percentage of black 
residents, and yielded real estate agents considerable profits by encouraging white homeowners 
to sell low and then re-selling the properties at above-market rates to incoming blacks.  The use 
of discriminatory mortgage lending practices referred to as redlining has further limited the areas 
in which blacks have been able to live, most notably preventing many members of this 
population from living in well-resourced neighborhoods (Massey & Denton, 1993).  While these 
and other sources of political inequality have contributed to the limited number of higher quality 
residential opportunities available to blacks, economic inequality also plays a significant role. 
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Black workers with similar educational backgrounds and employment experience continue to 
earn less income than their white peers (Wilson, 1996). This persistent race-based income 
inequality further limits blacks’ housing options in many areas, and together with political 
inequality, contributes directly to the ongoing race-based residential segregation patterns in many 
America metropolitan areas. 
 Race-based residential segregation is another proposed structural antecedent of inequality 
in the distribution of breast cancer subtype.  Residential segregation has been defined as “the 
extent to which individuals of different groups live in different neighborhoods within the region” 
(Reardon, 2006, p. 171). Massey & Denton (1993), among others, have argued that it is not the 
fact that different groups live in different areas that leads to worse social conditions for many 
minority groups, and for blacks in particular. Rather, it is the continuing unequal distribution of 
material, psychosocial, and other resources across neighborhoods that contribute to racial 
disparities in many aspects of American life, including health. Race-based residential segregation 
has been implicated in directly contributing to the observed racial disparities in health as well as 
perpetuating the complex relationship between race and low socioeconomic position (SEP), 
which is also widely believed to contribute to poor health outcomes (D. R. Williams & Collins, 
2001). The implication of this dual relationship is that race-based residential segregation may be 
a significant confounder or fundamental cause of racial inequalities in health (Massey & Denton, 
1993; Schulz, Williams, Israel, & Lempert, 2002).  As a result, evaluations of health disparities 
such as those seen in breast cancer subtype need to carefully consider what roles residential 
segregation and SEP may have in the creation or propagation of observed racial difference in 
health outcomes. Previous studies of disparities in breast cancer subtype have not taken structural 
factors such as residential segregation into full consideration.  The proposed conceptual model 
   
40 
 
attempts to elucidate how these larger structural factors may serve as antecedents to observed 
racial inequalities in breast cancer subtype. 
 
Relationship between Structural Factors and Breast Cancer 
Similarly, the impact of neighborhood socioeconomic status and/or race-based residential 
segregation on breast cancer outcomes has received relatively little attention.  Three recent 
studies have made important contributions to this very small body of literature. Barrett, et al, 
(2008) examined potential associations between presence of a distant metastasis at diagnosis and 
neighborhood characteristics of concentrated disadvantage, concentrated affluence, and upward 
socioeconomic change among women who were diagnosed with breast cancer in Cook County, 
Illinois between 1994 and 2000 (Barrett et al., 2008).  Each woman’s home address at the time of 
her diagnosis was geocoded to the census tract level, which once again served as the community-
level unit of analysis.  Census-based measures of concentrated disadvantage and concentrated 
affluence were created based upon the work of Sampson, Morenoff, and Earls (1999). A new 
composite measure comparing 1990 and 2000 U.S. Census data on the value of owner-occupied 
housing, percent of civilian labor force employed in professional or managerial roles, and the 
percent of college-educated adults within a census tract was use create the upward 
socioeconomic change score.  A multilevel logistic regression analysis identified concentrated 
affluence to be inversely related to distant metastasis at diagnosis (OR = 0.86, 95% CI = 0.79, 
0.93) while both concentrated disadvantage (OR = 1.23, 95% CI = 1.12, 1.36) and upward 
socioeconomic change (OR = 1.09, 95% CI = 1.01, 1.18) were both directly associated with 
increased risk of distant metastasis at diagnosis.   
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Warner & Gomez (2010) looked at potential relationships between black-white 
residential segregation and stage at breast cancer diagnosis, breast cancer-specific and all-cause 
mortality in California between 1996 and 2004. (Warner & Gomez, 2010)  Several notable 
findings were reported.  First, when compared to residents of low segregated regions (e.g., the 
Bay Area), black women living in neighborhoods with low percentages of blacks within a highly 
segregated regions (e.g., Los Angeles County) had higher odds of being diagnosed with distant-
stage cancer (OR = 2.11; 95% CI = 1.05-4.27). Moreover, black women who were diagnosed 
with breast cancer had lower levels of breast cancer specific (HR = 0.86; 95% CI = 0.76-0.97) 
and all-cause mortality (HR = 0.90; 95% CI = 0.82-0.99) when they lived in neighborhoods with 
at least 20% black residents.  The authors note that “this protective neighborhood effect persisted 
across nearly all levels and most dimensions [evenness, concentration, exposure, centralization, 
and clustering] of segregation, and seemed to be more pronounced in more segregated regions.” 
(p.401) While the authors had ER and PR status on approximately 70% of the included breast 
cancer cases, this information was only used to describe the overall study population and make 
statistical adjustments in the survival models.  It would be interesting to see if the distribution of 
ER-negative/PR-negative breast cancers – when treated as an outcome in and of themselves – 
follow the same general pattern of distant-stage diagnosis and survival among black women 
living in various levels of neighborhood and regional segregation. 
Research by Taylor, et al (2007) provides further evidence that discrimination may play a 
role in breast cancer among black women.  The authors looked at measures of perceived 
discrimination among 49,161 women in the Black Women’s Health Study and then examined the 
breast cancer incidence during a 6-year follow-up period. They found that women under the age 
of 50 who reported major discrimination in the workplace had an adjusted breast cancer 
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incidence rate ratio of 1.32 relative to women in the same age group who did not report 
workplace discrimination (95% confidence interval = 1.03-1.70).  In addition, women under age 
50 who reported that they had experienced all three domains of major discrimination – at the 
workplace, in housing, and by police – had a 1.48 adjusted incidence rate ratio relative to other 
women who had not experienced discrimination in any of those areas.  Similar relationships were 
not seen among women ages 50 or older, which may indicate that younger women are 
particularly susceptible to the deleterious health effects of major discrimination as suggested in 
the weathering hypothesis.  While the authors did adjust the incidence rate ratios for a large 
number of known and suspected breast cancer risk factors – age, BMI, education, age at 
menarche, menopausal status, use of hormone replacement therapy, age at first birth, oral 
contraceptive use, physical activity, alcohol use, and family history of breast cancer – they did 
not report on the hormone receptor status of the 593 self-reported breast cancer cases.  
Taken together, these three sets of findings suggest social mechanisms such as 
gentrification, residential segregation, and racial discrimination are related to stage at breast 
cancer diagnosis, cancer-specific mortality and all-cause mortality, and breast cancer incidence, 
respectively.  These larger structural issues may directly generate psychosocial stressors as 
illustrated in the conceptual model, but they may also work through important community level 
factors to initiate distress and activate harmful physiological mechanisms. 
 
Community-level Factors 
In keeping with the social ecological perspective, the community-level factors described 
in the conceptual model serve as an important intermediary between structural factors like race-
based residential segregation and gentrification and the individual-level psychosocial, 
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behavioral, and biological factors that may directly increase a woman’s risk of developing basal-
like breast cancer. For the purposes of this model, each of the community factors will be 
conceptualized as characteristics of a neighborhood.  Neighborhoods, in turn, will be 
conceptualized as the people and institutions that 1) reside within a defined geographical area 
and 2) are similarly influenced by the structural and cultural forces of the larger ecological 
systems (e.g., cities, states, nations) in which they are nested (Sampson, Morenoff, & Gannon-
Rowley, 2002).  It is important to note that defining meaningful neighborhood boundaries for 
public health research is one of several significant methodological challenges that remain in this 
field of research (Macintyre, Ellaway, & Cummins, 2002).  Frequently, neighborhoods are 
operationalized in terms of administrative boundaries, such as school districts and census tracts, 
which may not accurately reflect the full scope of the neighborhood definition stated above 
(Sampson et al., 2002).   Where appropriate, additional limitations of current neighborhood-level 
research methods will be cited, but a full review of the issues in this field are beyond the scope of 
this paper. 
Just as there are many ways in which neighborhoods can be defined, there are also many 
potential mechanisms that could produce the reported associations between neighborhoods and 
health. I take the perspective that the association between neighborhoods and health reflects a 
dynamic interaction between both compositional (e.g., the characteristics of people who live in a 
neighborhood) and contextual (e.g., the characteristics and resources of the neighborhood itself) 
effects (Bernard et al., 2007; Cummins, Curtis, Diez-Roux, & Macintyre, 2007; Macintyre et al., 
2002). From this vantage point, race-based residential segregation within a region and the 
underlying sociopolitical structures that support it have important implications in terms of the 
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social and physical environment in which they live. In turn, the social and physical environment 
may each affect the stressors and psychosocial buffers present within the neighborhood.  
As described in the previous section, race-based residential segregation negatively 
impacts minority residents in several domains. However, there may also be some advantages for 
minorities who live in neighborhoods with higher percentages of same-minority residents.  While 
these neighborhoods with higher ethnic group density may be economically and politically 
marginalized from a structural perspective, they may offer other community-level benefits 
(Pickett & Wilkinson, 2008).  These benefits may derive from shared alternative cultural 
frameworks and experiences among neighborhood residents, offering a refuge from the dominant 
and often disapproving cultural forces (James, 1993) and racist attitudes (Becares, Nazroo, & 
Stafford, 2009). By sharing in and supporting alternative cultural frameworks, neighborhoods 
with high minority ethnic density may afford some health benefits (Bécares et al., 2012), even in 
the face of the higher poverty rates frequently associated with these neighborhoods (Bécares, 
Cormack, & Harris, 2013) 
Large public housing projects may serve as an example of one type of neighborhood that 
historically had high percentages of minority residents and a high degree of economic, political, 
and social marginalization relative to the surrounding community. Two quotes from a New York 
Times article on life in the Cypress Hills Houses in Brooklyn illustrate the social complexity of 
life within public housing projects:  
If her mirror could grant her a wish, Ms. Lucas said, she would move them [her three 
children] far away, to a house with a porch. “A place,” she said, “where you could have 
peace of mind.”  
 
When asked about the good side of Cypress, he replied: “The friendships. When life is 
hard, people look out for each other here. When you don’t got no money, they give you 
food, they give you shelter.” He then motioned to his friend’s couch, the one he has slept 
on many a night.  (Brady, 2008) 
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These two residents succinctly capture popular notions of the dichotomous – yet by no means 
mutually exclusive – effects of living in urban public housing projects.  On one hand, life in such 
disadvantaged areas may consist of daily struggles to keep children safe and physically as well as 
emotionally healthy, among other daily hassles and chronic strains. However, residents may be 
able to make it through tough times by drawing from the tangible and emotional support offered 
by neighbors and local kin networks who take on family-like roles. Recent work by Keene and 
Ruel (2013) which examines the experiences of older public housing residents who were recently 
relocated provides further qualitative evidence of the importance of these relationships to long-
time residents. 
Neighborhood tenure may be an important individual-level factor that also contributes to 
social integration, conceptualized here as access to social ties and social support (D. Keene, 
Bader, & Ailshire, 2013). Long-term residents of neighborhoods experiencing upward 
socioeconomic change may view the neighborhood through a different set of narrative frames 
(Small, 2004; Tach, 2009).  In a recent study of a redeveloped, mixed income housing 
development in Boston, Tach (2009) found that longer-term residents had qualitatively different 
appraisals of their neighborhood than newcomers, and that these appraisals had a significant 
impact on their level of neighborhood engagement, and ostensibly their experience of social 
integration. In this particular neighborhood, residents with longer residential tenure viewed their 
current neighborhood conditions in a much more favorable light, whereas newcomers were less 
positive about their surroundings and thus less likely to engage with other members of their 
community.   
It is important to note that, post-redevelopment, the neighborhood 1) remained almost 
entirely minority (1% white in 1990 vs. 3% white in 2000), 2) had a higher but still low median 
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household income ($11,044 in 1990 vs. $27,646 in 2000), and 3) had a significantly higher rental 
occupancy rate (78% in 1990 vs. 95% in 2000).  These demographic changes do not reflect the 
stereotypical gentrified neighborhood, where the percentage of white residents, median income, 
and home ownership increase more dramatically.  Subsequently, the impact of residential tenure 
on social integration may be different in these neighborhoods. 
 
Relationship between Community Factors and Breast Cancer 
Given the relationships among social integration, psychosocial stress response (Bolger, 
Zuckerman, & Kessler, 2000), and several health behaviors and health outcomes (Tay, Tan, 
Diener, & Gonzalez, 2013), it is reasonable to hypothesize that social integration could have an 
indirect effect on breast cancer subtype via chronic exposure to psychosocial stressors and the 
subsequent physiological and behavioral stress responses. As with most other community-level 
constructs, the relationship between social integration and breast cancer subtype has not yet been 
tested.  However, the study by Barrett, et al (2008) described in the Structural Factors section 
provides some of the first empirically-based theoretical evidence for a relationship between 
neighborhood social networks and breast cancer disparities. The authors hypothesize that 
changes in neighborhood levels of social integration related to upward neighborhood 
socioeconomic change may contribute to the observed association between upward 
socioeconomic change and distant metastasis at diagnosis.  This hypothesis implies that long-
time black residents who remain in rapidly gentrified neighborhoods may suffer from worse 
breast cancer outcomes, due at least in part to the decreased social integration of the 
neighborhood. While the authors did report that black women also had a greater chance of 
having a distant metastasis at diagnosis (OR = 1.24, 95% CI = 1.03, 1.48), they did not discuss 
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the results of their neighborhood-level findings in terms of potential confounding with race due 
to race-based residential segregation, nor did they discuss whether whites and blacks might be 
equally affected by the neighborhood conditions measured. Further investigation of potential 
interactions among race, upward neighborhood socioeconomic change, social and physical order, 
and social integration within the context of breast cancer subtype is needed in order to test the 
relationships suggested in the conceptual model. 
 
Individual-level factors  
Demographic Factors 
 The pervasive influence of individual-level race, SEP, age, and residential tenure has 
already been noted in the previous sections of this paper and on all levels of the conceptual 
model (Figure 2-2).  With regard to the conceptual model, two different types of relationships are 
indicated. The dashed arrows represent the direct association between race and breast cancer 
hormone receptor status that is typically reported in the literature. However, there are several 
limitations in the way that both race and SEP have been conceptualized and assessed.  Much of 
the existing research has been conducted on an atheoretical basis, guided primarily by prevailing 
clinical, biological, and common wisdom.  Moreover, most of the previously described research 
has treated race either a categorical variable and/or as a variable that requires statistical control. 
Statistically significant differences across racial groups are therefore typically interpreted as an 
indication that race is a significant predictor of the dependent variable (LaVeist, 1994).  This is 
problematic in that the treatment of race as a simple categorical variable does not acknowledge 
the fact that race is, in fact, a complex construct that has significant implications for an 
individual’s ability to access critical social, political, and economic resources due to prevailing 
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racialized ideologies in the United States (Geronimus & Thompson, 2004).  The result of such 
racialized ideologies is that race and SEP remain tightly correlated within the United States, and 
structural factors such as race-based residential segregation help reinforce this troubling 
relationship (Schulz et al., 2002). The implications of these methodological weaknesses include 
the potential for research on the observed racial differences in breast tumor biology to be 
conducted and interpreted in a way that reinforces previously discredited notions of innate 
biological or genetic differences between racial groups, as demonstrated in the previously 
reviewed paper by Stark, et al (2010). 
In response to these limitations, the dotted arrows found on the conceptual model depict 
alternative and more complex avenues by which sociodemographic characteristics may interact 
with key variables on multiple levels to generate the observed social patterning of breast cancer 
hormone receptor status.  My focus is clearly on this set of demographic relationships, in an 
effort to provide greater context for those previously reported in the breast cancer literature.  I 
will continue to integrate discussion of demographic factors through the remainder of this paper, 
but will not address them individually. 
 
Psychosocial Stressors 
Several authors have suggested that exposure to stressors associated with disadvantaged 
status increases the black population’s vulnerability to mental and physical health problems 
(Geronimus & Thompson, 2004; Massey, 2004). Psychosocial stressors play a pivotal role in the 
conceptual model in that they may trigger biophysical responses leading to increased risk of 
basal-like breast cancer.  In addition, exposure to psychosocial stressors may lead individuals to 
engage in health behaviors that, while alleviating or numbing some of the distress, also lead to 
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biophysical pathways related to development of basal-like breast cancer (Jackson & Knight, 
2006). 
Perceived social isolation is the psychosocial stressor with the most compelling 
theoretical and empirical evidence linking it to the intermediate biological factors and ultimate 
health outcome of interest.  Social isolation has been repeatedly attributed to a wide variety of 
poor health outcomes, including increased risk of morbidity and mortality, although the precise 
mechanisms as to how social isolation impacts health remain unclear (Cacioppo & Hawkley, 
2003). Of particular relevance to the proposed conceptual model, a study by McClintock, et al 
(2005) described a mouse model that linked social isolation to the development of breast cancer 
outcomes that are similar to basal-like breast cancer in humans. In this study, genetically 
identical female Norway rats – which naturally engage in many social behaviors such as sleeping 
in groups and co-rearing pups – were randomized to either normal group housing or socially 
isolated cages.  All food and exercise conditions were held constant across both groups.  
However, the socially-isolated rats developed mammary carcinomas at a significantly higher rate 
than their group-housed counterparts.  Interestingly, the tumors also developed at a much earlier 
age than what is typically seen in this particular breed.  
More recent research in this area has been mixed. Williams, et al also found that females 
of the similarly sociable Sprague-Dawley mouse species suffered from increased rates of 
mammary tumor growth and tumor size when subjected to chronic stress in the form of social 
isolation (J. B. Williams et al., 2009). However, others have reported that a different bread of 
socially-isolated mice actually had lower numbers of mammary tumors than their group-housed 
counterparts (Hasen, O'Leary, Auger, & Schuler, 2010).  Melhem-Bertrandt & Conzen theorize 
that because Hasen, et al used a mouse model that was a p53 knockout (e.g., all cells in the 
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mouse had reduced levels of p53 tumor suppressor gene function), their findings are difficult to 
interpret. If Melhem-Bertrandt & Conzen’s argument is accepted, the sum of the limited mouse 
model findings suggest that the psychosocial stressor social isolation, which is also a stressor 
suspected to contribute to weathering in humans, is associated with increased rates of developing 
early-onset mammary tumors in rats.  Determining whether a similar phenomenon occurs in 
human populations, particularly blacks or other disadvantaged groups, is an important public 
health questions that needs to be addressed. 
 Perceived discrimination is another social stressor that has been implicated in poor 
physical and mental health among minorities (Williams, Neighbors, & Jackson, 2003). As 
discussed in the Structural Factors section, perceived discrimination was associated with 
increased risk for breast cancer among black women under the age of 50 (T. R. Taylor et al., 
2007).  Breast cancer subtype was not included in their analysis, but because ER-negative breast 
cancers are more common among premenopausal black women than any other demographic 
group (Carey et al., 2006), it is reasonable to suggest that differences in the etiology and risk 
factors of ER-negative tumors are at least one reason why a similar increased risk of breast 
cancer among women 50 years old or older who perceived major discrimination was not 
observed.  Further research is needed to test this hypothesis. 
 Finally, perceived neighborhood safety is another psychosocial stressor that has recently 
been implicated as a breast cancer risk factor.  As conceptualized here, perceived neighborhood 
safety incorporates both perceptions of crime and unsafe housing within the neighborhood.  
Gelhert and colleagues have reported in conference settings and in personal communications that 
the number of neighborhood sexual assaults, personal experience of sexual assault, and poor 
neighborhood housing conditions were each associated with more aggressive breast cancer 
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subtypes, as defined by triple-negative hormone receptor status and glucocorticoid receptor-
positive tumors (Gehlert et al., 2010).  Full results of this study of 139 black women who lived in 
Chicago’s South Side and were diagnosed with breast cancer are not yet available in manuscript 
form, but this novel finding linking specific types of psychosocial stressors to both biological 
measures of deregulated stress response (i.e., flat diurnal cortisol curves) and more aggressive 
breast cancer subtypes is particularly intriguing. 
 
Psychological Distress 
According to several stress process models, distress is an important mediator of both 1) 
the direct effects of community-level factors such as neighborhood disorder on health outcomes 
and 2) the indirect health effects of such community-level factors, as mediated by exposure to 
individual-level psychosocial stressors such as perceived social isolation (Hill et al., 2005; 
Pearlin, 1989; S. E. Taylor, Repetti, & Seeman, 1997). I will focus on the latter construction, 
which places distress as a key proximal factor to the physiological and behavioral responses that 
are thought to directly influence cellular changes responsible for determining breast cancer 
subtype.   This distinction is important because, as discussed earlier, simply being exposed to 
various community-level factors or psychosocial stressors may not necessarily generate distress 
that results in the key physiological or behavioral responses described below.  While a full 
review of individual coping resources and other potential moderators of the relationship between 
psychosocial stressors and resultant distress is beyond the scope of this paper, their role must still 
be acknowledged and considered when testing the individual-level relationships specified in the 
conceptual model. 
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Physiological Responses 
When distress does occur, the hypothalamic–pituitary–adrenal (HPA) is activated. This 
well-designed neuroendocrine feedback system serves to prepare the body for immediate and 
effective responses to stressful situations, such as signaling for increased cortisol secretion in 
order to utilized stored energy and respond to physical threats (Traustadóttir, Bosch, & Matt, 
2005).  However, the inability to efficiently turn off the HPA axis following chronic exposure to 
stress – commonly referred to as allostatic load – has been associated with disregulation of 
glucocorticosteriods, neurotransmitters, and inflammatory cytokines (McEwen, 1998). Allostatic 
load is believed to have detrimental effects to existing cellular systems, including disregulation 
and acceleration of normal cellular aging process (McEwen & Wingfield, 2003). The cancer-
related impact of these processes will be described in more detail in the Molecular Changes 
sections below. 
 
Behavioral Response 
Dietary behaviors represent a potentially important mediator on the pathway from 
community-level factors to breast cancer-related molecular changes. For example, 
neighborhoods with a high percentage of minority residents are less likely to have chain 
supermarkets located nearby (Morland, Wing, Diez Roux, & Poole, 2002). As a result, residents 
of these neighborhoods tend have limited access to good quality fresh fruits and vegetables 
(Moore & Diez Roux, 2006; Zenk et al., 2006).   Minority neighborhoods also tend to have a 
greater number of small convenience stores, liquor stores, and fast food restaurants that sell 
relatively inexpensive, highly palatable foods of generally poor nutritional quality (Baker, 
Schootman, Barnidge, & Kelly, 2006). The combination of restricted availability of healthy 
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foods with the pervasive presence of less healthful comfort and fast foods has a significant 
impact on the dietary behaviors of local residents (Baker et al., 2006). In addition to the direct 
relationship between community-level material resources and dietary behaviors, eating comfort 
foods, which are typically high in fat and/or sugar, may also be an individual-level response to 
distress that actually helps dampen the stress response system that is activated via the HPA axis 
(Jackson & Knight, 2006; Jackson, Knight, & Rafferty, 2010).   
One potential implication of these dietary behaviors is that black women who live in 
disadvantaged neighborhoods and are exposed to significant amounts of stress may not be 
getting enough folate in their diet.  Folate, which is found in many green leafy vegetables and 
fruits, has an important role in the maintenance of proper DNA methylation patterns described in 
the following section (Cacioppo & Hawkley, 2003).  With regards to breast cancer specifically, 
there is evidence that women who consume less folate in their diets are more likely to be 
diagnosed with estrogen receptor negative tumors (Zhang et al., 2005).  Recent findings from the 
Black Women’s Health Study also found that total vegetable intake was inversely associated 
with risk of ER-negative / PR-negative breast cancer, even after adjusting for 15 other known or 
suspected breast cancer risk factors, such as family history of breast cancer and use of hormone 
replacement therapy (Boggs et al., 2010). The authors also reported a trend towards a similar 
inverse relationship between cruciferous vegetables (e.g., broccoli, collard greens, cabbage) and 
ER-negative / PR-negative breast cancer, but it did not reach statistical significance.  Perhaps 
even more importantly, the fact that no significant relationship between ER-positive breast 
cancers and vegetable intake was identified again suggests variation in the etiology and risk 
factors for breast cancer subtypes.  Whether there is a similar relationship between basal-like 
breast cancers and vegetable and/or folate consumption remains to be determined. 
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Molecular Changes: The role of epigenetics 
 Stress-related responses such as allostatic load and food preference provide an empirical 
basis for connecting distress to racial disparities in the incidence of basal-like breast cancer via 
two molecular pathways: epigenetics and human stress genomics.  Epigenetic regulation of gene 
expression takes place above the genome level – that is, epigenetic changes are not alterations in 
the DNA code, but rather changes in the molecular environment that either increase or decrease 
the production of proteins from specific genes (Petronis, 2010).  The three major types of 
epigenetic alterations are changes in DNA methylation patterns, histone tail modifications, and 
changes in chromatin structure.  I will focus on DNA methylation, as it is the best-understood 
epigenetic mechanism and has been the most researched epigenetic mechanism with regards to 
breast cancer. 
While a detailed discussion of the DNA methylation process is beyond the scope of this 
paper, the basic principles can be described as follows: DNA methylation occurs when a group 
of molecules attach methyl groups to the specific areas of a gene’s promoter region, thereby 
preventing the “reading” of the gene and the formation of the gene product.   DNA methylation 
(and de-methylation) is a generally stable set of process that can be replicated from parent cell to 
daughter cell.  However, an individual’s DNA methylation patterns may also change over time.  
Disruptions in the DNA methylation process are thought to be especially important in the 
development and proliferation of cancerous cells (Esteller, 2008; Gronbaek, Hother, & Jones, 
2007). In order for cancerous cells to continue to grow and divide at a rapid pace, tumor 
suppressor genes need to be silenced via a deleterious gene mutation or gene-specific 
hypermethylation. Two recent studies have indicated that as cells age, chromosome instability 
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increases and hypermethylation of tumor suppressor genes is more prevalent (Ahuja, Li, Mohan, 
Baylin, & Issa, 1998; Issa, 2000).  Additionally, tumor enhancing genes (also known as 
oncogenes) need to be turned on via general hypomethylation.  The exact mechanisms that cause 
gene-specific hypermethylation and general hypomethylation in cancerous cells are not yet well 
characterized.  However, there is increasing evidence that cellular aging, as well as elements of 
the physical and social environment, may play a role in this process (Szyf et al., 2008). 
Some of the more interesting evidence for the relationship between cellular aging and 
hypermethylation comes from a study of monozygotic twins (Fraga et al., 2005).  Monozygotic 
twins result from the early separation of a single egg into two genetically identical embryos. In 
this study, monozygotic twins who were less than 28 years old, and particularly those who were 
still in early childhood, exhibited very similar DNA methylation patterns.  However, sets of 
twins who were older than 28, especially those who were middle aged and older, were found to 
have significantly different DNA methylation patterns across their genome.  Whether the 
evolution of an individual’s DNA methylation pattern is the result of more typical cellular aging 
processes or repeated environmental and/or psychosocial insults that are part of the weathering 
process has yet to be determined.  
As noted by Joanovic, et al (2010), the primary epigenetic mechanism of interest with 
regards to estrogen receptor expression status has been DNA hypermethylation of the estrogen 
receptor alpha (ER-) gene promoter region, ESR1.  This focus is intuitive, as increased 
methylation of a promoter region results in the down regulation or silencing of gene’s 
expression, which would thereby explain the lack of estrogen receptors in an ER-negative tumor.  
Indeed, in vitro laboratory work conducted in the mid-1990’s supports this developmental 
pathway for ER-negative tumors.  However, subsequent clinical studies have produced 
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conflicting results (Ferguson, Lapidus, Baylin, & Davidson, 1995; Weigel & deConinck, 1993).  
In one study, 76% of ER-negative breast cancers were found to have a methylated ER-α gene, 
while 22% of ER-positive tumors also demonstrated methylation of the ER-α gene (Wei et al., 
2007).  These results suggest that selective methylation of the ER-α gene plays an important, yet 
not necessary nor sufficient, role in the development of basal-like breast cancers. Most recently, 
Gaudet, et al (2009) found no clear association between promoter methylation levels and ER- 
expression levels, but methylation of the progesterone receptor PGR promoter was associated 
with lower levels of ER- expression.(Gaudet et al., 2009) Additional work is needed in this area 
to determine the true role of DNA methylation in the loss ER- expression in ER-negative 
tumors. 
 Other types of epigenetic regulation may also be associated with the development of ER-
negative and/or basal-like breast cancers.  For example, ER-negative breast tumors display 
hypomethylation and subsequent over-expression of several breast cancer-related genes (Feng et 
al., 2007; Widschwendter et al., 2004).  These more global patterns of hypo- and 
hypermethylation have recently been explored in breast cancer tumors.  Christensen, et al 
(Christensen et al., 2010) recently tested 162 primary breast tumors found that triple-negative 
hormone status was significantly associated with altered DNA methylation patterns in a set of 
130 cancer-related genes.  When the researchers used an unsupervised clustering method to 
generate 8 distinct methylation-based classes of breast cancers, they also found trends towards 
increased methylation with increasing total dietary folate intake.  However, none of the 8 
methylation profiles were significantly associated with ER or triple-negative status, therefore no 
direct associations among hormonally-defined subtypes, methylation-defined subtypes, and 
folate intake can be made at this time.  It is important to note though that this sample consisted of 
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primarily of white women (72.7% white, 8.1% black) and contained a higher percentage of ER-
positive tumors (88%) than in the total Kiaser Permanente Northern California cancer registry 
(78%).  A more diverse sample may yield different findings. 
 
Molecular changes: The role of human stress genomics 
 Epigenetic mechanisms are but one way gene expression is modulated.  Recently, there 
has been growing interest in exploring the role of neuroendocrine stress responses to changes in 
gene expression profiles.  Cole (2010) provides an important review of pervious work in this 
area, which he refers to as “human stress genomics.”  He notes that early research on the 
expression of stress-related genes has been difficult to replicate for several reasons, including the 
high level of statistical noise that is due to both measurement error and true biological variability 
across time, individuals, and tissues within individuals. In addition, Cole argues that the prior 
conception of “stress genes” is faulty in that “it is unlikely that any gene is regulated solely and 
consistently by glucocorticoids or catecholamines, and thus constitutes a pure, reliable indicator 
of stress uncontaminated by other regulatory influences.” (p.957)   
 In response to these limitations, Cole suggests in favor of taking an abstractionist 
approach to functional genomic data.  This perspective focuses on the biological causes and 
consequences of gene expression, either in terms of the differential expression patterns of 
functionally-defined groups of genes (i.e., receptor activity genes), or in terms of the common 
regulatory pathways that lead to differential gene expression (i.e., decreased glucocorticoid 
receptor (GR)-mediated transcription). Cole argues that these abstractionist approaches have, and 
will continue to, yield more consistent results due to both the focus on more biologically stable 
targets of functional gene groups and regulatory pathways, as well as the statistical advantages of 
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looking at approximately 200 higher order gene function themes vs. approximately 22,000 
individual level genes. 
A recently published report provided the first evidence that individuals who have high 
self-reported levels of social isolation express genes that lead to over-activation of genes 
involved in the inflammatory response system, and under-activation of glucocorticoid response 
elements which are critical to the anti-inflammatory response system (Cole et al., 2007) While 
Cole and colleagues did not address the molecular mechanisms responsible for the up- and 
down-regulation of specific genes, a later paper put forth a helpful illustration (see Figure 2-3) of 
the potential pathways (Cole, 2009).  The figure shows a dynamic flow of information from the 
social environment to protein formation, health, and behaviors via perceptions formed in the 
central nervous system, neuroendocrine responses, and transcriptional regulation of gene 
expression.  This is a promising framework for exploring how exactly exposure to social 
stressors that more prevalent among black women may result in increased incidence of 
aggressive breast cancer subtypes within this population. 
Not only is the general stress genomics framework developed by Cole and colleagues 
promising, but their specific findings regarding the potential social regulation of the 
glucocorticoid pathway may be of particular relevance to the subtype-specific risk of developing 
breast cancer.  
Summary and Conclusions 
Taken together, this suggests a potential biological mechanism that may at least partially 
explain why black women, who may have unique and/or additional exposure to neighborhood-
level stressors, are at a greater risk for developing triple-negative breast cancers.  Moreover, if 
this hypothesized relationship is accurate, it may add to our general understanding of the 
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complex ways in which neighborhoods and stress may contribute to health inequalities across 
racial groups. 
 
Limitations of the Conceptual Model 
The current conceptual model faces several limitations.  At the individual level, personal 
attributes such as coping style and personality are not addressed.  These factors may play a 
significant role in moderating an individual’s perceptions of and response to stressful situations 
(Pruessner et al., 1997).   However, most of the remaining empirical and theoretical questions 
reside at the community level of analysis.  While each of the constructs described in the 
conceptual model have documented relationships with other health outcomes, the literature 
relating neighborhood factors to breast cancer subtype is virtually non-existent.  This model is 
derived largely from indirect evidence of neighborhood effects on general stress and health 
processes, which themselves are not always well-defined. 
 
 Implications for Future Research 
Numerous complex social and behavioral factors related to the stress and weathering 
processes may underlie the widely-reported racial inequality in breast cancer subtype. The 
proposed conceptual model provides one theoretically-driven structure by which these complex 
relationships may begin to be disentangled. Initiating interdisciplinary, theoretically-driven 
research projects to evaluate what mechanisms are plausible both at the social and biological 
level is essential in order to move this field forward and spur the develop of more effective 
intervention programs.   
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Policy makers, social advocates, and public health practitioners need to take special 
notice of this type of interdisciplinary health research, particularly as it relates to common 
biological processes that may impact other common complex diseases.  For example, allostatic 
load-mediated cellular and DNA changes may be a common pathway for social conditions to 
differentially affect the health of disadvantaged minority populations. The implications of such a 
common pathway would go well beyond breast cancer and could contribute to broader health 
disparities.
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Figure 2-1:  Relationship between triple-negative and basal-like breast cancers 
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Table 2-1:   Prevalence of estrogen receptor-negative, triple-negative and basal-like breast cancer subtypes among white and black 
women diagnosed with breast cancer 
 
Breast 
cancer 
subtype 
Geographic location & 
ascertainment period 
Reference Sample size: % with specified 
subtype: 
Black-White 
OR 
(95% CI) Black White Black White 
Basal-like North Carolina, 1993-1996  Carey et al. (2006) 196 300 26.5 16.0 2.1 (1.3-3.4) 
 North Carolina, 1993-2001 Millikan et al. (2008) 581 843 20.1 12.2 n/a 
Triple 
negative 
Atlanta, 1990-1992 *  Trivers et al. (2009) 116 476 48.3 16.6 2.98 (2.12-4.20) 
California, 1999-2003    Bauer et al. (2007) 2,587 36,671 24.6 10.8 1.77 (1.59-1.97) 
California, 1999-2004   Parise et al. (2009) 2,936 39,501 27.0 11.5 1.88 (1.69-2.09) 
Single hospital, 1998-2006 Stead et al. (2009) 177 148 29.4 12.8 3.0 (1.6-5.4) 
California & Utah, 1997-2008 Kwan et al. (2009) 155 1,943 28.4 10.5 n/a 
ER-, PR- US hospital registries, 1990 Gapstur et al. (1996) 1,114 11,715 35.0 20.0 2.29 (1.99-2.64) 
 Hawaii & LA, 1993-1996  Setiawan et al. (2009) 420 701 30.9 17.6 n/a 
 SEER-11, 1992-1998    Tarone and Chu (2002) 8,870 101,140 34.4 19.4 n/a 
 SEER-9, 1990-1997         Joslyn (2002) 7,332 85,377 33.7 18.9 n/a 
 SEER-13, 1992-2004 ** Hausauer et al. (2007) 19,105 193,513 22.2 12.6 n/a 
  * Study population consisted only of women ages 20-54  
** Study population consisted only of women ages 50 and older 
 63 
 
Table 2-2: Sample of the sociodemographic risk factors for triple-negative breast cancer; statistically significant results in bold 
 Trivers et al., 2009 Kwan et al., 2009 Millikan et al., 2008 Parise et al., 2009 
 Group OR  95% CI Group OR  95% CI Group OR  95% CI Group OR  95% CI 
Race 
Black 2.98 2.12-4.20 Black 3.14 2.12-4.66 Black 2.1 1.6-2.9 Black 1.88 1.69-2.09 
White --- reference White --- reference White --- reference White --- reference 
Age at 
diagnosis, 
in years 
20–39 2.13 1.34-3.39 <50 2.78 1.99-3.90 < 40 4.5 2.7-7.3 < 50 1.21 1.14-1.29 
40–49 1.09 0.72-1.64 50-64 1.99 0.85-1.62 40-49 2.6 1.7-3.9 ≥ 50 --- reference 
50–54 --- reference ≥ 65 --- reference 50-59 1.8 1.1-2.8    
      ≥ 60 --- reference    
Education 
< College 
grad 
1.35 0.97-1.89 
Not measured Not measured Not measured 
College 
grad + 
--- reference 
SES 
 
≤200% 
PI* 
1.22 0.77-1.93 
Not measured Not measured 
SES 1 – 
low
†
 
1.12 
(1.01-
1.24) 
201–
700% PI 
--- reference 
SES 2 1.11 
(1.01-
1.21) 
SES 3 1.09 
(1.01-
1.19) 
>700% PI 1.06 0.71-1.57 SES 4 1.09 
(1.01-
1.18) 
   
SES 5 - 
high 
--- reference 
Insurance 
status 
Private --- reference 
Not measured Not measured Not measured Public/ 
none 
1.51 0.91-2.53 
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Table 2-3: Sample of the reproductive risk factors for triple-negative breast cancer; statistically significant results in bold 
 Trivers et al., 2009 Kwan et al., 2009 Millikan et al., 2008 Phipps et al., 2008 
 Subgroups OR  95% CI 
Subgroup
s 
OR  95% CI Subgroups OR  95% CI 
Subgroups 
OR  95% CI 
Age at 
menarche, in 
years 
< 12 1.55 1.08-2.23 
Not measured 
< 13 1.3 0.9-1.7 < 13 1.1 0.7-1.7 
12+ --- reference ≥ 13 --- reference ≥ 13 --- reference 
Age at first 
birth, in years 
Nulliparous --- reference Nulliparous --- reference Nulliparous --- reference < 20 --- reference 
< 18 2.83 1.30-6.14 < 26 1.28 0.90-1.82 < 26 1.9 1.2-3.0 20-24 1.1 0.6-2.1 
18+ 0.99 0.67-1.48 ≥ 26 0.93 0.63-1.38 ≥ 26 1.2 0.7-2.1 25-29 1.3 0.6-2.8 
         ≥ 30 0.7 0.2-2.3 
Number of 
full-term 
births 
0 --- reference 0 --- reference 0 --- reference 1 --- reference 
1–3 0.98 0.65-1.45 1-2 1.11 0.78-1.58 1-2 1.6 1.0-2.7 2 0.8 0.3-1.7 
≥ 4 2.40 1.24-4.64 ≥ 3 1.18 0.81-1.72 ≥ 3 1.7 1.0-2.9 ≥ 3 0.8 0.3-1.7 
Time since 
last birth, in 
years 
Nulliparous --- reference 
Not measured Not measured Not measured ≤ 5 2.25 1.16-4.36 
> 5 0.95 0.64-1.42 
Breastfeeding 
duration, in 
months 
Never --- reference Never --- reference Never --- reference Never --- reference 
<12 mo. 1.02 0.70-1.48 0-3 mo. 1.04 0.71-1.52 0-3 mo. 1.1 0.7-1.9 < 6 mo. 0.9 0.5-1.6 
≥12 mo. 0.83 0.48-1.43 ≥ 4 mo. 0.78 0.59-1.03 ≥ 4 mo. 0.7 0.5-1.1 ≥ 6 mo. 0.5 0.3-0.9 
Age at 
menopause, 
in years Not measured Not measured Not measured 
< 45 --- reference 
45-54 0.9 0.4-2.0 
≥ 55 1.2 0.5-3.0 
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Table 2-4: Sample of additional biobehavioral risk factors for triple-negative breast cancer; statistically significant results in bold 
  * BMI values are associated with the following clinical designations: <25 = under- to normal weight; 25 – 29.9 = overweight; ≥30 = obese  
** Type of hormone replacement therapy is indicated by: (1) = estrogen only therapy;  (2) = estrogen-progestin therapy 
 Trivers et al., 2009 Kwan et al., 2009 Millikan et al., 2008 Setiawan et al., 2009 
 Groups OR 95% CI Groups OR 95% CI Groups OR 95% CI Groups RR 95% CI 
Body mass 
index (BMI)* 
 
< 25 --- reference < 25 --- reference < 25 --- reference < 25 --- reference 
25.0-29.9 1.90 1.27-2.85 25-29 1.33 0.98-1.81 25-29 1.4 1.0-2.2 25-<30 0.98 0.79-1.21 
≥ 30 1.89 1.22-2.92 ≥30 1.04 0.75-1.45 ≥30 1.3 0.8-1.9 ≥ 30 0.79 0.60-1.03 
BMI, pre-
menopausal 
women Not measured 
< 25 --- reference < 25 --- reference 
Not measured 25-29 1.82 1.03-3.24 25-29 1.7 1.0-3.1 
≥30 1.97 1.03-3.77 ≥30 1.6 0.9-2.7 
BMI, post-
menopausal 
women Not measured 
< 25 --- reference < 25 --- reference < 25 --- reference 
25-29 1.08 0.73-1.59 25-29 1.2 0.7-3.0  25-<30 1.00 0.77-1.30 
≥30 0.76 0.49-1.17 ≥30 1.0 0.5-1.7 ≥ 30 0.69 0.49-0.98 
Hormone 
replacement 
therapy use** 
Not measured 
Never --- reference Never --- reference Never use --- reference 
Ever 0.97 0.72-1.31 Ever 0.8 0.5-1.3 Former use 1.11 0.81-1.51 
      Current (1)  1.21 0.79-1.85 
      Current (2) 1.11 0.82-1.51 
Alcohol use Never --- reference Never --- reference Never --- reference 0 drinks/day --- reference 
<7 drinks 
per week 
0.72 0.50-1.04 Ever 0.98 0.73-1.30 Ever 0.9 0.6-1.2 
< 2 drinks 
per day 
1.21 0.99-1.48 
≥7 drinks 
per week 
0.72 0.44-1.17 
   
   ≥ 2 drinks 
per day 
1.71 1.19-2.46 
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Footnotes for Tables 2-4: 
Trivers et al., 2009:  
 Odds ratios are weighted, compared to the ER/PR+, HER2- subtype and are adjusted for 
race, age and stage (race models are adjusted for age & stage; age models are adjusted for 
race & stage; stage models are adjusted for age & race) 
 
 Kwan et al., 2009:  
 Case-only odds ratios adjusted for age at diagnosis, race/ethnicity except in models with age 
at diagnosis or race/ethnicity as main predictors 
  
Parise et al., 2009: 
 Adjusted odds ratios. 
  
Millikan et al., 2008: 
 Case-only odds ratios compare basal-like to luminal A breast cancer.  Age odds ratio is 
adjusted for race; race odds ratio is adjusted for age, and all remaining odds ratios are 
adjusted for both age and race.  
  
Phipps et al., 2008:   
 Odds ratios are adjusted for age and diagnosis/reference year.  Number of live births, age at 
first live birth, and breastfeeding were coadjusted for each other. 
 
Setiawan et al., 2009: 
 Authors report that “Results were stratified on age at recruitment, year of recruitment, 
race/ethnicity, type of menopause, and study center and were mutually adjusted for age at 
menarche, age at first birth, number of children, BMI, alcohol intake, duration of hormone 
therapy, and family history of breast cancer.” 
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Figure 2-2: Conceptual model of the relationship between stress and basal-like breast cancer 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Solid arrows = direct (box to box) or moderating (box to arrow) relationships  
Heavy dashed arrow = direct association between race and breast cancer subtype typically reported in the literature. 
Dotted arrows = alternative avenues by which sociodemographic factors may interact with key constructs  
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Figure 2-3:  Illustration of social signal transduction set forth in Cole, S. W. (2009). Social 
Regulation of Human Gene Expression. Current Directions in Psychological 
Science, 18(3), 132-137. 
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CHAPTER 3 
Neighborhood Sociodemographics and Hormone Receptor Status among California Women 
Diagnosed with Breast Cancer 
 
Introduction 
Racial/ethnic disparities have been well documented across the breast cancer continuum 
(Bigby & Holmes, 2005; Jones & Chilton, 2002; Newman & Martin, 2007). When compared to 
white women, black women have lower levels of access to quality mammography services 
(Hirschman, Whitman, & Ansell, 2007), experience longer diagnostic and treatment delays 
(Gorin, Heck, Cheng, & Smith, 2006; Kerner et al., 2003), are more likely to receive suboptimal 
care once treatment is initiated (Bradley, Given, & Roberts, 2002), and are more likely to die of 
the disease (Albain, Unger, Crowley, Coltman, & Hershman, 2009; Jatoi, Becher, & Leake, 
2003; Wojcik, Spinks, & Optenberg, 1998).  
Disparities in several clinical features of breast cancer are also well-documented (Amend, 
Hicks, & Ambrosone, 2006; DeSantis, Jemal, & Ward, 2010), and the differential distribution of 
breast cancer subtypes are particularly noteworthy. While breast cancer subtype is ideally 
defined directly via gene expression profiles of tumor tissue, routinely collected 
immunohistochemical markers such as the concentration of three specific hormone receptors are 
frequently used as proxy measures (Won et al., 2013). Numerous studies have found that, 
relative to whites, black women with breast cancer are more likely to be diagnosed with tumors 
that express very low levels of estrogen receptors (ER), progesterone receptors (PR), and human 
epidermal growth factor receptors (HER2) (Gapstur, Dupuis, Gann, Collila, & Winchester, 1996; 
 83 
 
Hausauer, Keegan, Chang, & Clarke, 2007; Joslyn, 2002; Tarone & Chu, 2002). Commonly 
referred to as triple negative breast cancer, this particular subtype is associated with larger and 
higher-grade carcinomas at the time of diagnosis (Parise, Bauer, Brown, & Caggiano, 2009), and 
these aggressive tumors are not responsive to current adjuvant treatments such as Tamoxifen and 
Herceptin (Kang, Martel, & Harris, 2008; Reis-Filho & Tutt, 2008).  As a result, triple negative 
tumors are associated with lower 5-year survival rates even after adjusting for other clinical 
features, such as stage at diagnosis and tumor grade (Bauer, Brown, Cress, Parise, & Caggiano, 
2007; Boyle, 2012). Because breast cancer subtype is thought to be determined at the time the 
tumor begins to develop, observed differences in subtype distribution across groups should not 
be influenced by access to breast cancer screening, diagnostic, and treatment resources (Morris et 
al., 2007).  
Differences in the population-level distribution of breast cancer subtype are therefore an 
early, clinically-meaningful source of inequality in the breast cancer experience, but the origins 
of this disparity remain unclear. Women from low socioeconomic areas also appear to have 
higher rates of triple-negative tumors (Gordon, 1995; Vona-Davis & Rose, 2009), but little work 
has been done to disentangle the associations among race, socioeconomic status (SES), and the 
differential distribution of breast cancer subtypes. The few studies that have examined SES in 
relation to breast cancer subtype have been limited by the conceptualization and measurement of 
SES (Dunn, Agurs-Collins, Browne, Lubet, & Johnson, 2010). State and national cancer registry 
data are frequently used in these types of analyses, but given the lack of individual-level 
socioeconomic data collected by the cancer surveillance systems, researchers frequently resort to 
using area based socioeconomic information as proxy measures. This approach is problematic, as 
the area-based measures capture more than just approximate individual-level SES (Geronimus & 
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Bound, 1998). As a result, broader structural issues that are 1) related to both the racial and 
socioeconomic composition of the area, and 2) could independently contribute to the observed 
disparities status in breast cancer subtype cannot be adequately addressed using this approach. 
 Residential segregation is one such structural factor that reinforces the complex 
relationship between race and SES within the United States (Schulz, Parker, Israel, & Fisher, 
2001; Williams & Collins, 2001), and it is receiving increasing attention in the breast cancer 
disparity literature. Recent work from Warner and Gomez (2010) suggests that black women 
living in metropolitan areas with high levels of race-based residential segregation were 
significantly more likely to be diagnosed with advanced stage breast cancer and die of the 
disease if they lived in a block group with more non-black residents. The relationship remained 
significant after adjusting for neighborhood-level socioeconomic status, suggesting that factors 
other than material resources may contribute to this risk. Warner and Gomez posit that one such 
factor may be reduced access to social support within neighborhoods consisting of fewer co-
ethnic residents. Other work suggests that blacks living in more integrated neighborhoods may 
also be subjected to greater levels of discrimination (Hunt, Wise, Jipguep, Cozier, & Rosenberg, 
2007; Welch, Sigelman, Bledsoe, & Combs, 2001) which has also been identified as a potential 
risk factor for the development of breast cancer among black women (Taylor et al., 2007).   
 The weathering hypothesis (Geronimus, 1992; Geronimus & Thompson, 2004) provides 
a useful theoretical framework for exploring the potential role of these and other neighborhood-
related psychosocial factors related to breast cancer disparities, as it emphasizes the role of 
social, political, and economic marginalization on health outcomes, particularly among black 
women in early to middle adulthood (Geronimus, Hicken, Keene, & Bound, 2006). In this study, 
I use the weathering framework to explore the distribution of double negative (estrogen and 
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progesterone receptor negative, also abbreviated as ER-/PR-) breast cancers
 
across the same 
study population as Warner and Gomez and determine whether the social patterning of this 
breast cancer subtype is similar to the patterns reported for stage at diagnosis and mortality. 
HER2 receptor status was excluded from this analysis for several reasons. First and foremost, 
The American Society of Clinical Oncology and the College of American Pathologists did not 
recommend routine testing for HER2 receptor status in invasive breast cancers until 2007 (Wolff 
et al., 2007), and the NCI Surveillance, Epidemiology and End Results (SEER) Program Central 
Cancer Registries were not required to collect this data until 2010 (Reichman et al., 2010). As a 
result, nearly 50% of the otherwise eligible cases are missing HER2 data.  Despite the large 
percentage of missing HER2 data, I elected to retain the 1996-2004 sampling frame used by 
Warner & Gomez to build off of their findings.  This sampling frame also brackets the extensive 
residential segregation data available from the 2000 Census. To my knowledge, metropolitan and 
micropolitan residential segregation data are not yet available for the 2010 Census, nor for any of 
the five-year American Community Survey data sets. Due to these methodological 
considerations, I chose double negative breast cancer as the primary subtype of interest for this 
analysis, using the double positive (ER+/PR+) subtype as the reference category. Additional 
information regarding the missing HER2 data and plans for related exploratory analyses are 
provided in the Measures section. 
 I hypothesize that at the population level, both black and Hispanic women with breast 
cancer will have lower proportions of ER-/PR- disease with increasing concentrations of co-
ethnic neighborhood residents. I anticipate that this relationship will be robust to adjustment for 
neighborhood socioeconomic status, and will be more pronounced 1) within metropolitan areas 
that have high levels of race-based residential segregation, and 2) among younger women. 
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Methods 
Study Subjects 
 Cases for this analysis were drawn from the California Cancer Registry (CCR). The CCR 
has been tracking cancer cases across the state of California since 1988 and has received gold 
certification status from the North American Association of Central Cancer Registries 
(NAACCR) for data quality and completeness. The individual-level CCR data has been 
geocoded to the 2000 Census block group level and linked to the 21,390 California census block 
groups that are currently included in the California Neighborhoods Data System (CNDS). The 
CNDS was developed by researchers at the Cancer Prevention Institute of California (CPIC) to 
aid in the area-based analysis of cancer risk factors and survival (Gomez et al., 2011). The 
CNDS is a collection of neighborhood characteristics derived from the 2000 Census as well as 
other types of local information, such as 15 unique measures of racial/ethnic residential 
segregation from the RAND Center for Population Health and Health Disparities ("Segregation 
Indices Data Series," 2000). 
 Matching the catchment period used by Warner and Gomez (2010) and centered on the 
2000 decennial census, all non-Hispanic white and non-Hispanic black female residents of 
California who were diagnosed with a first primary, invasive breast cancer between January 1, 
1996 and December 31, 2004 were eligible for the study. A total of 124,852 women met these 
initial criteria. Women whose address could not be directly geocoded to a census block group (n 
= 5,807; 4.7%) or lived in a block group outside of the 25 California metropolitan statistical 
areas or MSAs (n = 4,279; 3.4%) were removed from the sample. Of the 114,766 remaining 
eligible women, 25,124 (21.9%) were missing estrogen and/or progesterone receptor data and 
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14,400 (12.5%) had complete data but were not classified in either the reference (ER+/PR+) or 
outcome (ER-/PR-) categories. These women were also excluded. A total of 75,242 women met 
the final eligibility criteria and were included in the following analyses. 
 Both the University of Michigan Health and Behavioral Sciences Institutional Review 
Board and the California Health and Human Services Agency’s Committee for the Protection of 
Human Subjects reviewed and approved the study protocol. 
 
Measures 
Individual-level variables  
 Breast cancer subtype. While much of the current literature on breast cancer subtype uses 
the three hormone receptor definition, the primary outcome measure for this analysis is based on 
estrogen receptor and progesterone receptor (commonly abbreviated ER/PR) only. The CCR has 
been collecting ER and PR status since 1990, but only began collecting information on the third 
hormone receptor, HER2, in 1999. For the first few years after HER2 data collection began, the 
rate of missing data was quite high. As a result, only 38,863 (51.7%) of the 75,242 otherwise 
eligible cases have complete data on all three hormone receptors. While not completely 
concordant, the ER-/PR- subtype is a reasonable approximation of distribution of triple-negative 
breast cancer. 
 Race/Ethnicity. Individual race/ethnicity data as reported in the CCR is first included as 
an independent variable to model differences in breast cancer subtypes and their predictors 
across the racial/ethnic groups. Racial/ethnic categories are subsequently used to stratify the 
sample for within-group analyses. In this analysis, the two racial/ethnic groups are mutually 
exclusive, representing non-Hispanic whites (hereafter referred to as whites) and non-Hispanic 
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blacks (hereafter, blacks).  Race/ethnicity information is derived from patients’ medical records, 
and have been shown to be of good quality (Clegg et al., 2007; Gomez & Glaser, 2006).  
 Age. Age at the time of diagnosis is included as a continuous variable in all models. 
Additionally, to assess for possible variation in ER-/PR- odds ratios across the adult lifespan, 
age-stratified models were also constructed. The three stratifying age groups were constructed 
such that the middle age group – women between the ages of 45 and 64 – could be compared to 
both younger and older groups of women diagnosed with breast cancer. This middle age group is 
of particular importance from a weathering perspective, as the premature onset of age-related 
illness and disability quickly accumulate among minority group members during this period 
(Geronimus et al., 2006; Geronimus & Snow, 2013).  
 The designated age groups also allow for a crude proxy measure of menopausal status. 
Menopausal status is not included in the CCR records, but the designated age groups roughly 
correspond to pre-menopausal (under age 45), peri- and post-menopausal (ages 45 to 64), and 
elderly (ages 65 and older) status in Western cultures (Gold, 2011; Hill, 1996). Approximation of 
menopausal status may be important, as multiple studies have found that the risk of hormone 
receptor negative breast cancer is greater among pre-menopausal women (Forshee, Storey, & 
Ritenbaugh, 2003; Tarone & Chu, 2002)   
 Year of diagnosis. To account for the increase in ER and PR reporting rates over the 
course of the study, the year of diagnosis was included. This variable also adjusts for the widely 
reported decline in ER+/PR+ cancers diagnosed among white women following the 2002 release 
of Women’s Health Initiative data linking use of hormone replacement therapy to increased risk 
of breast cancer (DeSantis, Howlader, Cronin, & Jemal, 2011; Ravdin et al., 2007). 
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 Marital status. Standard demographic categories of single never married, separated, 
divorced, widowed, and unknown are compared against the reference group of married women. 
 Payer source at diagnosis. Data regarding the primary payer source at the time of breast 
cancer diagnosis was categorized into five groups: private insurance; uninsured or self-pay; 
publicly funded (e.g., Medicare, Medicaid, Indian Health Service, or county-funded); military 
sponsored (e.g., TriCare or Veterans Administration); and unknown. While representing only 
one dimension of socioeconomic status, primary payer at diagnosis is the CCR variable that may 
best approximate individual-level socioeconomic status (Chan, Gomez, O'Malley, Perkins, & 
Clarke, 2006).   
 Tumor characteristics. Given the previously reported relationships between tumor stage, 
tumor grade, and ER/PR subtype (Boyle, 2012; Parise et al., 2009) both clinical factors were 
controlled for in all analyses. Tumor stage was assessed using the SEER 1977/2000 summary 
stage categories of local, regional, distant, and unknown. Tumor grade was categorized into four 
groups of increasing severity as well: I, II, III/IV, and unknown. 
 
Metropolitan- and neighborhood-level variables 
 Residential racial segregation. The black-white entropy index (H) was selected as the 
primary measure of metropolitan-level racial segregation. Also known as the information theory 
index or Theil’s H, the black-white entropy index is a measure of what Massey and Denton 
(1989) refer to as “evenness,” or the degree to which the selected racial groups present in an area 
(i.e., MSA) are evenly distributed across its component parts (i.e., census tracts). The measure is 
similar in concept to the more widely used dissimilarity index, but is considered to be the 
superior due to its spatial properties and its ability to be mathematically decomposed into 
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meaningful parts (Reardon & Firebaugh, 2002). Scores on this measure range from 0, meaning 
all census tracts have the same racial composition as the entire MSA, to 1, which means that 
each census tract is comprised of only one racial/ethnic group (Iceland, 2004). The black-white 
entropy index scores for the 25 California MSA scores into tertiles. MSA’s in the highest tertile 
were categorized as highly segregated MSA’s, whereas the bottom two tertiles became the low 
segregation comparison group. 
 Neighborhood racial concentration. Complementing the MSA-level measures of 
segregation, measures of neighborhood (block group) racial/ethnic concentration are also 
included in the analyses. These measures are also derived from the 2000 decennial census and 
capture the percent non-Hispanic black residents living within block groups comprised of 
approximately 1,000 residents. Notably, the neighborhood racial concentration measures are 
assessed at a smaller geographical unit than the roughly 4,000-resident census tracts that are 
component parts of the entropy indices. 
 Neighborhood-level socioeconomic status. The CNDS includes several single-variable 
measures of block group-level socioeconomic status (SES) from the 2000 Census, as well as a 
previously validated composite measure of socioeconomic status comprised of block group-level 
education, employment, income, and housing indicators (Yost, Perkins, Cohen, Morris, & 
Wright, 2001). Given previously identified conceptual and statistical issues with composite area-
based socioeconomic measures (Geronimus & Bound, 1998), block group median household 
income was chosen as the primary indicator of neighborhood socioeconomic status. Secondary 
analyses replacing median household income with the composite measure – of which median 
household income is one component – were also conducted. 
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Data analysis 
 Descriptive statistics of the full study population and each racial/ethnic subgroup are 
reported in Tables 1 – 3. Means and standard deviations were calculated for the continuous 
variables, while frequencies are listed for each categorical measure. Statistically significant 
differences between racial/ethnic subgroups were assessed for each independent variable using 
unadjusted t-tests and chi-square tests, respectively. Inter-group differences with p-values ≤ 0.05 
are noted in the tables and highlighted in the results section. 
 To test the hypothesized relationships among neighborhood racial/ethnic concentration, 
metropolitan-level racial segregation, and odds of ER-/PR- breast cancer subtype, two-level 
population average generalized estimating equation models were constructed using the XTGEE 
command in Stata 13 (StataCorp, 2013), specifying a binomial distribution, logit link, 
exchangeable correlation structure, and robust standard errors. This statistical approach takes 
into account the clustering of individual cases within census block groups, but avoids the 
modeling and distribution assumptions that underlie multilevel mixed effects models (Hubbard et 
al., 2010). Given the large number of clusters (block groups), the relatively small number of 
cases per cluster (mean = 4.3 cases per block group in the full sample; range = 1 to 67), and the 
conceptual emphasis on the effects of cluster-level predictors, population average models are 
well-suited for addressing the current research questions (Hosmer, Lemeshow, & Sturdivant, 
2013). The odds ratios generated by population average models are interpreted in a similar 
manner as standard logistic regression models, with the parameter estimates describing the effect 
of each predictor averaged across all block groups. 
 To examine the intersecting relationships (Kelly, 2009) among individual race/ethnicity, 
neighborhood- and MSA-level characteristics, and ER/PR subtype, the two-level population 
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average models were first constructed for the full study sample, then stratified by race/ethnicity. 
Each of the full and racial/ethnic subsamples were then further stratified by 1) MSA-level black-
white entropy index, and 2) individual-level dichotomous categories for age at diagnosis. A two-
sample t-test was used to examine whether the observed differences in the magnitude of the 
regression coefficients across strata were statistically significant. 
 
Results 
Descriptive statistics 
 Tables 1 through 3 illustrate the unadjusted demographic characteristics of the study 
sample across all individual, neighborhood, and metropolitan-level variables. Compared to white 
women, the mean age at diagnosis was significantly lower for blacks (p < 0.01). Black women in 
this sample were less likely than white women to be: married (p < 0.01); have private health 
insurance (p < 0.01); be diagnosed with an early stage (p < 0.01), low grade (p < 0.01), or 
ER+/PR+ tumor (p < 0.01). The median neighborhood household income for black women was 
significantly lower than that of whites (p < 0.01), while the mean percentage of black (p < 0.01) 
neighborhood residents was much greater than that of white women (p < 0.01). Black women 
were more likely to reside in a highly-segregated metropolitan area than white women (p < 0.01). 
 
Multivariable analyses 
 Given the significant variation across racial/ethnic groups described in Table 1, all 
models adjusted for individual-level sociodemographic characteristics (age, marital status, 
insurance status, and race/ethnicity in the non-stratified models) as well as clinical features (year 
of diagnosis, stage at diagnosis, and tumor grade).  In both the total population and within 
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race/ethnicity, age at diagnosis was inversely associated with the odds of having ER-/PR- breast 
cancer (data not shown). Increasing year of diagnosis, stage at diagnosis, and tumor grade were 
each associated with substantially higher odds of ER-/PR- cancer across all racial/ethnic 
subgroups (data not shown). In the total population and among white women only, being single 
was associated with approximately 10% lower odds of ER-/PR- subtype relative to married 
women (p < 0.01; data not shown), while having military-sponsored health insurance rather than 
private insurance was associated with a nearly 40% increase in odds of ER-/PR- (p = 0.01; data 
not shown).  
 The covariates most central to the aim of this study were measured at the neighborhood 
(block group) and MSA levels. As such, the odds ratios for only these variables are reported in 
Tables 4 through 6. Previously documented racial/ethnic disparities in the odds of ER-/PR- 
breast cancer were observed in the full study sample.  Relative to white women and holding all 
other individual- and neighborhood-level variables constant, the odds of having ER-/PR- breast 
cancer was 94% higher for blacks (p < 0.01; see Table 4, Model 3).  Neighborhood 
socioeconomic status was also significantly associated with breast cancer subtype in the fully-
adjusted model, as every $10,000 increase in block group median household income was 
associated with a 2.6% decrease in the odds of ER-/PR- breast cancer (p < 0.01). In addition, 
each 10-point increase in the percentage of black neighborhood residents was modestly 
associated with a 1.7% decrease in the odds of ER-/PR- breast cancer (p = 0.09). 
 Different patterns emerged when the full study sample was stratified by race/ethnicity 
(Table 5). Among whites, a 10% increase in the block group percentage of black residents 
resulted in a 3.9% increase in the odds of ER-/PR- diagnosis (p = 0.02), but this relationship was 
completely attenuated by the addition of block group median household income to the model 
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(OR = 1.01, p = 0.42). As observed in the full sample, increasing block group median household 
income was significantly associated with lower odds of ER-/PR- subtype among white women. 
This relationship between neighborhood SES and ER/PR subtype was not found among 
blacks (Table 5). Instead, bock group percentage of black residents was a statistically stronger 
predictor, with every 10% increase in black concentration resulting in a 2.7% decrease in odds of 
ER-/PR- subtype in the fully-adjusted model (p = 0.03). Unlike the results for the white 
subsample, the relationship between percentage of black neighborhood residents and odds of ER-
/PR- breast cancer was even stronger when neighborhood SES was taken into account (OR = 
0.97, p = 0.01). The difference in the coefficients for the neighborhood racial composition 
variable between the white subpopulation and the black subpopulation was statistically 
significant (p < 0.01) 
When the racial/ethnic subpopulations were further stratified by metropolitan-level 
segregation (Table 6) and age at diagnosis (Table 7), differences were observed across strata for 
black women, but were largely absent within the white subpopulation. For example, black 
women living in highly segregated MSAs had lower odds of ER-/PR- breast cancer with 
increasing neighborhood black percentage (OR = 0.97, p = 0.04), and to a lesser extent, 
increasing neighborhood SES (OR = 0.97, p = 0.10).  However, these relationships were not 
statistically significant among black women living in less segregated areas (SES OR = 0.99, p = 
0.80; percent black OR = 0.99, p = 0.80). This difference in odds ratio across MSA segregation 
levels was not statistically significant. 
Unique age group-specific patterns were seen within the black subpopulation. For 
example, black women diagnosed with breast cancer before age of 45 had 7.2% lower odds of 
ER-/PR- breast cancer with each $10,000 increase in block group median household income (p = 
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0.03), but did not benefit from increasing percentages of black neighborhood residents. The 
opposite relationships were seen among black women diagnosed at age 65 or above, as they had 
a 8.4% lower odds (p < 0.01) with every 10% increase in neighborhood percentage of black 
residents, but no significant change in odds relative to neighborhood SES. Among black women 
in the primary age group of interest (ages 45 to 64), neither the neighborhood SES or 
neighborhood racial/ethnic composition variables were significantly related to odds of ER-/PR- 
breast cancer. While neighborhood median household income and the percentage of black 
residents within the neighborhood were significantly related to odds of ER-/PR- breast cancer 
within the youngest and oldest age groups, respectively, comparisons of the coefficients across 
age groups indicate that they are not significantly different from one another.  
When the analysis was restricted to whites, the both the segregation level- (Table 6) and 
age-stratified models (Table 7) yielded the same general patterns that were observed in the full 
white subpopulation. At both segregation levels and across all three age groups, increasing 
neighborhood median household income was associated with significantly lower odds of ER-
/PR- breast cancer. The difference in coefficients across segregation level and age group strata 
were not statistically significant. Also as seen in the full white subpopulation, the percentage of 
black residents within the block group was positively associated with the odds of having ER-
/PR- breast cancer among white women in both more- and less-segregated MSAs and among 
white women diagnosed between the ages of 45 and 64. However, as in the full white sample, 
this association was no longer significant in any stratified white subgroup once neighborhood 
median household income was included in the model, and the difference in coefficients across 
age groups was not significant. 
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Discussion 
 Among black women diagnosed with breast cancer, living in neighborhoods with greater 
concentrations of black residents reduced the odds of being diagnosed with ER-/PR- breast 
cancer. As hypothesized, the risk-reducing effects were particularly strong within metropolitan 
areas that were among the most racially segregated areas in California, based on the black-white 
entropy index. In both the full sample of black breast cancer patients and among black residents 
of highly-segregated areas, the relationship between black residential concentration and ER/PR 
status became even stronger when neighborhood socioeconomic status was accounted for. These 
findings build upon the results of Warner & Gomez (2010), who found similar relationships 
among racial concentration, stage at diagnosis, and mortality among black Californian women 
diagnosed with breast cancer during the same time period. Taken together, these findings suggest 
that, for black women with breast cancer, the benefits of living in more densely black 
neighborhoods may operate through non-socioeconomic pathways that may potentially include 
reduced exposure to racial discrimination (Hunt et al., 2007; Welch et al., 2001), greater 
acceptance of alternative cultural frameworks (James, 1993) and/or greater opportunities for 
social support (Das-Munshi, Becares, Dewey, Stansfeld, & Prince, 2010; Keene & Geronimus, 
2011). 
 While this finding and the potential explanations are consistent with the conceptual 
model, the significant racial concentration-associated reduction in odds of ER-/PR- subtype seen 
only among black women ages 65 and over ran counter to my hypothesis. One plausible 
biological explanation is that the ER-/PR- breast cancers diagnosed in younger women may have 
a stronger genetic contribution. Mutations in the BRCA1 gene are thought to be responsible for 
roughly 10% of pre-menopausal breast cancers (Lakhani et al., 2002; Mavaddat et al., 2012), and 
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approximately 70% of tumors diagnosed among BRCA1 mutation carriers are triple-negative 
(Atchley et al., 2008; Foulkes, Smith, & Reis-Filho, 2010; Mavaddat et al., 2012). The higher 
prevalence of BRCA1 mutation associated breast cancers may thus partially obscure the 
relationship between ER-/PR- and other non-inherited risk factors.  
 From a more socially-oriented perspective, the impact of psychosocial exposures within a 
neighborhood may change over the life course, with older black women potentially deriving 
greater benefits from living among more co-ethnic neighbors. What remains to be examined is 
how these benefits may be accrued, and if the benefits vary across various levels of residential 
tenure, residential stability, and neighborhood poverty. Two studies conducted in the Chicago 
metropolitan area are worth noting. Keene, Bader, and Ailshire (2013) found that the positive 
relationship between residential tenure and available social support was even stronger in more 
impoverished Chicago neighborhoods. Barrett and colleagues (2008) found that women living in 
Cook County, Illinois census tracts that experienced upward socioeconomic change between 
1990 and 2000 actually had higher risks of being diagnosed with late-stage breast cancer. 
Considering that increasing neighborhood-level socioeconomic status commonly coincides with 
decreasing percentages of minority residents (i.e., gentrification; see Goetz, 2011) it would be 
important to further disentangle how neighborhood racial/ethnic composition and socioeconomic 
status may relate to neighborhood tenure, and how these relationship may be of particular import 
to the availability of social support and the subsequent health and well-being of elderly black 
women.  
 The lack of neighborhood tenure and other social-contextual data needed to disentangle 
these complex relationships is one of several study limitations. The analytic plan for this study 
was built around the availability of block group-level sociodemographic data and metropolitan-
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level racial/ethnic segregation data generated from the 2000 Census. Choosing this source of 
sociodemographic information was essential for addressing the research questions at the optimal 
geographic levels and developing a data set that closely relates to that used by Warner and 
Gomez. However, the resulting limitations on the California Cancer Registry catchment period 
meant that a more coarse approximation of breast cancer subtype would be needed. Future 
studies that make use of block group level data from later 5-year American Community Survey 
estimates and calculate new black-white entropy indices from the 2010 Census are needed to 
have a sufficient number of cases with data on all three hormone receptors.   
 Data limitations at the individual level are also worth noting. The large number of women 
missing either ER or PR information could introduce bias into study sample. The single point of 
measurement for neighborhood-level characteristics could mask the importance of duration 
and/or critical period exposure to neighborhood-level factors.  The lack of life course residential 
and socioeconomic histories could prove to be problematic if 1) a particular threshold level of 
exposure to neighborhood-level factors must be met before the individual-level psychosocial, 
behavioral, and biological processes more proximal to specific breast cancer subtypes take hold, 
or if 2) there is a critical developmental period for neighborhood-level exposures during the life 
course other than immediately prior to diagnosis of breast cancer.  The importance of the 
duration and timing of neighborhood-level exposures to the development of specific breast 
cancer subtypes is not yet known, thus the impact of these data limitations cannot be fully 
evaluated. Finally, the dearth of individual-level biopsychosocial data prevents the analysis of 
potential pathways linking neighborhood-level factors to the two breast cancer subtypes.  
 Despite these limitations, this study makes an important contribution to the breast cancer 
disparities literature: the increased risk of more aggressive breast cancer subtypes routinely 
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observed among black women may be at least partially mediated via social-structural 
mechanisms. Research that focuses solely on ancestry-based genetic risk factors for breast cancer 
subtypes fails to address how the phenotype of being a minority in America shapes ones lived 
experiences, and how those lived experiences may in turn shape the odds of developing a 
specific breast cancer subtype. The psychosocial and physiological effects of increased exposure 
to racial/ethnic discrimination and/or decreased support and acceptance for individuals whose 
sociocultural identities are outside of the dominant norms may represent two pathways by which 
neighborhood factors influence the development of triple-negative breast cancer. To properly 
investigate these and other complex, dynamic relationships, additional research guided by 
current empirical evidence and theory in multiple disciplines ranging from molecular cancer 
biology to social epidemiology is needed. 
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Tables 
Table 3-1.  Individual-level descriptive statistics, by race/ethnicity 
 Total sample White cases Black cases 
N (%) 75,242 100% 69,614 92.5% 5,628 7.5% 
Age (years):       
mean, SD 60.3 ± 14.1 61.6 ± 13.9 56.8 ± 13.9 
Marital status:       
Single, never married 9,226 12.3% 7,904 11.4% 1,322 23.5% 
Married 42,328 56.3% 40,115 57.6% 2,213 39.3% 
Separated 706 0.9% 527 0.8% 179 3.2% 
Divorced 8,598 11.4% 7,706 11.1% 892 15.8% 
Widowed 13,158 17.5% 12,292 17.7% 866 15.4% 
Unknown 1,226 1.6% 1,070 1.5% 156 2.8% 
Primary insurer:       
Uninsured / self-pay 648 0.9% 542 0.8% 106 1.9% 
Private 48,044 63.9% 44,707 64.2% 3,337 59.3% 
Public 22,551 30.0% 20,647 29.7% 1,904 33.8% 
Military 676 0.9% 604 0.9% 72 1.3% 
Unknown 3,323 4.4% 3,114 4.5% 209 3.7% 
Summary stage:       
Localized 47,655 63.3% 44,670 64.2% 2,985 53.0% 
Regional 24,781 32.9% 22,519 32.3% 2,262 40.2% 
Remote 2,347 3.1% 2,037 2.9% 310 5.5% 
Unknown 459 0.6% 388 0.6% 71 1.3% 
Grade:       
I 16,226 21.6% 15,652 22.5% 574 10.2% 
II 29,008 38.6% 27,288 39.2% 1,720 30.6% 
III & IV 23,923 31.8% 21,033 30.2% 2,890 51.4% 
unknown 6,085 8.1% 5,641 8.1% 444 7.9% 
ER-PR status:       
ER+ / PR+ 58,673 78.0% 55,401 79.6% 3,272 58.1% 
ER- / PR- 16,569 22.0% 14,213 20.4% 2,356 41.9% 
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Table 3-2. Neighborhood-level sociodemographic measures: means and standard deviations 
for the 17,477 study neighborhoods, by individual cases’ racial/ethnic group 
 
 White cases Black cases 
Neighborhood socioeconomic indicator:     
Median household income, 1999 US dollars $63,170 ± 29,429 $44,063 ± 21,421 
Mean Yost index 0.518 ± 0.927 -0.320 ± 0.844 
Neighborhood racial concentration:     
Mean % non-Hispanic White 65.3% ± 22.0% 25.6% ± 24.8% 
Mean % non-Hispanic Black 3.4% ± 06.1% 29.2% ± 26.4% 
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Table 3-3. Metropolitan-level measures of racial residential segregation: counts and 
percentages of study cases residing in each tertile of the black-white entropy index, 
by individual race/ethnicity 
 
 White cases Black cases 
n (%) residing in a metropolitan statistical area within:   
Lowest black-white entropy index tertile 12,121 17.4% 135 2.4% 
Middle black-white entropy index tertile 15,666 22.5% 936 16.6% 
Highest black-white entropy index tertile 41,827 60.1% 4,557 81.0% 
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Table 3-4. Adjusted
1
 odds ratios (and 95% confidence intervals) for the association between 
ER-/PR- vs. ER+/PR+ subtype and individual-level race, neighborhood-level 
median household income and neighborhood racial concentration, California 
Cancer Registry 1996-2004 
 
 
ER-/PR- vs. ER+/PR+ Subtype 
OR (95% confidence intervals) 
 
Model 1 Model 2 Model 3 
Individual race: 
      White (ref.) 1.00 
 
1.00 
 
1.00 
 Black 1.86 (1.74-1.99) 1.96 (1.81-2.13) 1.94 (1.78-2.11) 
Block group level demographics: 
      Median household income
2 
0.98 (0.97-0.98) 
  
0.97 (0.97-0.98) 
% Black
3 
  
0.99 (0.98-1.01) 0.98 (0.96-1.00) 
1
  Adjusted for age at diagnosis, year of diagnosis, marital status, insurance status, stage at diagnosis, and tumor 
grade 
2  
units = $10,000 (1999 U.S. dollars) 
3 
units = 10-point change in percent of racial/ethnic group 
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Table 3-5. Race/ethnicity specific adjusted
1
 odds ratios (and 95% confidence intervals) for the 
association between ER-/PR- vs. ER+/PR+ subtype and neighborhood-level median 
household income & racial/ethnic concentration, California Cancer Registry 1996-
2004 
 
 
ER-/PR- vs. ER+/PR+ Subtype 
OR (95% confidence intervals) 
 
Model 1 Model 2 Model 3 
White women:       
Median household income
2 
0.97 (0.97-0.98)   0.97 (0.97-0.98) 
% Black
3 
  1.04 (1.01-1.07) 1.01 (0.98 -1.05) 
Black women: 
      Median household income
 
0.99 (0.96-1.02) 
  
0.98 (0.95-1.01) 
% Black
 
  
0.97 (0.95-1.00) 0.97 (0.95-0.99) 
1
  Adjusted for age at diagnosis, year of diagnosis, marital status, insurance status, stage at diagnosis, and tumor 
grade 
2  
units = $10,000 (1999 U.S. dollars) 
3  
units = 10-point change in percent of racial/ethnic group 
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Table 3-6. Segregation level stratified, race/ethnicity specific adjusted
1
 odds ratios (and 95% 
confidence intervals) for the association between ER-/PR- vs. ER+/PR+ subtype and 
neighborhood-level median household income & racial/ethnic concentration, 
California Cancer Registry 1996-2004 
 
 
ER-/PR- vs. ER+/PR+ Subtype 
OR (95% confidence intervals) 
 
Model 1 Model 2 Model 3 
White women       
Residing in highly segregated 
MSAs:       
Median household income
2 
0.98 (0.97-0.99)   0.98 (0.97-0.99) 
% Black
3 
  1.05 (1.01-1.09) 1.02 (0.99-1.07) 
Residing in less segregated 
MSAs:       
Median household income
 
0.97 (0.96-0.99)   0.98 (0.96-0.99) 
% Black
 
  1.09 (1.01-1.18) 1.06 (0.99-1.15) 
Black women     
  
Residing in highly segregated 
MSAs:       
Median household income
 
0.98 (0.95-1.01)   0.97 (0.94-1.00) 
% Black
 
  0.98 (0.95-1.00) 0.97 (0.95-1.00) 
Residing in less segregated 
MSAs:       
Median household income
 
0.99 (0.93-1.06)   0.99 (0.92-1.06) 
% Black
 
  0.99 (0.88-1.11) 0.99 (0.87-1.11) 
1
  Adjusted for age at diagnosis, year of diagnosis, marital status, insurance status, stage at diagnosis, and tumor 
grade 
2  
units = $10,000 (1999 U.S. dollars) 
3  
units = 10-point change in percent of racial/ethnic group 
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Table 3-7. Age stratified, race/ethnicity specific adjusted
1
 odds ratios (and 95% confidence 
intervals) for the association between ER-/PR- vs. ER+/PR+ subtype and 
neighborhood-level median household income & racial/ethnic concentration, 
California Cancer Registry 1996-2004 
 
 
ER-/PR- vs. ER+/PR+ Subtype 
OR (95% confidence intervals) 
 
Model 1 Model 2 Model 3 
White women       
Age at diagnosis < 45 years:       
Median household income
2 
0.96 (0.94-0.98)       0.96 (0.94-0.98) 
% Black
3 
  1.03 (0.95-1.12) 0.99 (0.91-1.08) 
Age at diagnosis = 45 to 65 years:       
Median household income
 
0.97 (0.96-0.98)   0.98 (0.96-0.99) 
% Black
 
  1.06 (1.00-1.11) 1.03 (0.98-1.08) 
Age at diagnosis ≥ 65 years:       
Median household income
 
0.98 (0.97-1.00)   0.98 (0.97-1.00) 
% Black
 
  1.01 (0.96-1.07) 1.00 (0.94-1.06) 
Black women       
Age at diagnosis < 45 years:       
Median household income
 
0.94 (0.88-1.00)   0.93 (0.87-0.99) 
% Black
 
  0.97 (0.92-1.03) 0.96 (0.90-1.02) 
Age at diagnosis = 45 to 65 years:       
Median household income
 
0.98 (0.95-1.02)   0.98 (0.95-1.02) 
% Black
 
  1.01 (0.97-1.04) 1.00 (0.97-1.04) 
Age at diagnosis ≥ 65 years:       
Median household income
 
1.04 (0.98-1.10)   1.01 (0.95-1.08) 
% Black
 
  0.90 (0.86-0.95) 0.91 (0.86-0.95) 
1
 Adjusted for age at diagnosis, year of diagnosis, marital status, insurance status, stage at diagnosis, and tumor 
grade 
2 
units = $10,000 (1999 U.S. dollars) 
3 
units = 10-point change in percent of racial/ethnic group 
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CHAPTER 4 
Individual and Neighborhood Characteristics, Perceived Unfair Treatment, and Diurnal 
Cortisol Patterns among Adults in Detroit 
 
Introduction 
Perceived discrimination or unfair treatment has been linked to a wide range of 
conditions, including: depressive symptoms during pregnancy (Ertel et al., 2012), weight change 
(Cozier, Wise, Palmer, & Rosenberg, 2009), obesity (Hunte & Williams, 2009), high blood 
pressure (Dolezsar, McGrath, Herzig, & Miller, 2014), physical and mental health recovery after 
an injury (Sullivan, Scott, & Trost, 2012), and even breast cancer incidence (Taylor et al., 2007). 
However, the psychological, behavioral, and biological mechanisms by which perceptions of 
unfair treatment may contribute to these conditions remain an area of considerable research 
interest (Gibbons et al., 2014; Williams & Mohammed, 2009). 
 Researchers have suggested that, as a form of chronic or acute stress, perceptions of 
unfair treatment may repeatedly activate the hypothalamic-pituitary-adrenal axis (HPA), 
eventually leading to its dysregulation and a cascade of harmful downstream physiological 
consequences (Skinner, Shirtcliff, Haggerty, Coe, & Catalano, 2011). Measurement of salivary 
cortisol levels over the course of one or more days is one way to approximate HPA axis activity 
with relatively low participant burden (Kraemer et al., 2006). Current evidence suggests that 
alterations in the typical diurnal pattern of salivary cortisol secretion – namely, the shallow 
decrease in salivary cortisol levels between morning wake-up and evening bedtime – may reflect 
dysregulation of the HPA axis negative feedback loop (Spiegel, Giese-Davis, Taylor, & 
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Kraemer, 2006), and that these alterations are associated with a similar set of negative physical 
and mental health outcomes as perceived unfair treatment (Hajat et al., 2013; Kjolhede, 
Gustafsson, Gustafsson, & Nelson, 2014; Marchand, Durand, Juster, & Lupien, 2014). However, 
the casual relationships driving these associations have not been established, and it is possible 
that some of the physical and/or mental health outcomes could be influencing salivary cortisol 
levels, either directly or indirectly via other biopsychosocial mechanisms. 
 With these limitations in mind, very few studies that have directly examined potential 
relationships between perceived unfair treatment and daily cortisol decline. Fuller-Rowell, Doan, 
and Eccles (2012) found that increasing levels of perceived discrimination was associated with a 
more shallow daily cortisol decline among white study participants. The opposite was true 
among black participants, as they exhibited a steeper and presumably more healthy daily cortisol 
decline when reporting higher levels of perceived discrimination. In their study of Mexican 
American adolescents, Zeiders, Doane, and Roosa (2012) found no significant relationship 
between daily cortisol decline and perceived discrimination, although they did observe 
significant associations with other aspects of the diurnal cortisol pattern. 
 Despite the current lack of published significant relationships between daily cortisol 
decline and perceived discrimination among minority group members, previous research has 
found that the daily cortisol decline is typically flatter among members of minority racial/ethnic 
groups (Cohen et al., 2006; DeSantis et al., 2007; Hajat et al., 2010; Karlamangla, Friedman, 
Seeman, Stawksi, & Almeida, 2013), and individuals with lower levels of socioeconomic status, 
whether it is measured in terms of education (Dowd et al., 2011) or an index of  income and 
wealth (Hajat et al., 2010). However, these sociodemographic patterns are not consistently 
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observed across all studies, probably due in some part to the wide variation in salivary cortisol 
sampling protocols and methods of statistical analysis (Dowd, Simanek, & Aiello, 2009).  
Another potential source of ambiguity is the fact that the social patterning of exposures 
that may be associated with chronic stress and subsequent daily cortisol decline have not been 
fully examined. Three recent population-based studies have used multilevel modeling techniques 
to begin looking at the relationship between diurnal cortisol patterns and both individual- and 
neighborhood-level stressors. Using data from the Multi-Ethnic Study of Atherosclerosis 
(MESA) Stress Study, Hajat et al (2010) found that black and Hispanic participants had lower 
waking cortisol levels relative to whites, and that these differences remained statistically 
significant after adjusting for known health behaviors (e.g., smoking) and psychosocial factors 
(e.g., cynical hostility) that have been previously associated with cortisol levels.  Black 
participants also had flatter rates of late-day cortisol decline compared to whites, and this finding 
was also robust to adjustment for health behaviors and psychosocial factors.   
Do and colleagues used the same data set but focused their analyses on neighborhood-
level covariates derived from the MESA Community Survey (Do et al., 2011). Reports of higher 
levels of neighborhood violence were associated with lower cortisol levels at wake-up and 
slower rates of morning cortisol decline among residents enrolled in the MESA Stress study.  
Lower levels of social cohesion and higher levels of disorder were also associated with a trend 
toward lower waking cortisol levels, but these patterns were less consistent than those associated 
with neighborhood violence. Do and colleagues reported that the black and Hispanic participants 
in the MESA Stress study were much more likely to reside in neighborhoods that were in the 
lowest tertile for social cohesion and the highest tertiles for violence and disorder.  
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Race/ethnicity was controlled for in the multilevel models and was not reported as a separate 
predictor of cortisol levels. 
It is important to note that the MESA Community Survey was comprised of a separate set 
of respondents who lived within one mile of each MESA Stress Study participant and were 
sampled via random digit dialing or list-assisted methods. While this design allows for an 
independent assessment of neighborhood-level conditions, it cannot directly assess how 
individual perceptions of one’s neighborhood may relate to individual diurnal cortisol patterns. 
Additionally, it is not known how the interaction between individual- and neighborhood-level 
sociodemographic characteristics may influence individual perceptions of the neighborhood, and 
how this interplay may relate to diurnal cortisol patterns.  
The third population-based study to use a multilevel approach for modeling diurnal 
cortisol patterns utilized data from the Chicago Community Adult Health Study (CCAHS). Karb 
et al (2012) reported that participants living in areas with higher levels of perceived 
neighborhood stress exhibited a flatter slope for cortisol decline over the course of the day.  
Similar cortisol patterns were found when examining objective measures of neighborhood 
stressors derived from the study’s systematic social observation protocol, Census data, and 
Unified Crime Reports. Individual-level characteristics including gender, educational attainment, 
depression, alcohol use, and physical activity were also associated with various aspects of the 
diurnal cortisol pattern, but the neighborhood level effects remained statistically significant after 
adjusting for these factors. Notably, Karb and colleagues did not find any significant 
relationships between race and waking cortisol level, morning cortisol increase, or daily cortisol 
decline. 
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As with the MESA Study, it is important to note how the subjective neighborhood level 
variables were generated in the CCAHS. Karb et al report that their perceived neighborhood 
stress measure was comprised of five scales – perceived disorder, perceived violence, 
neighborhood safety, physical hazards, and quality of neighborhood services – that  were 
included in the  CCAHS resident surveys and aggregated up to create standardized 
neighborhood-level scores. In this case, the originally measured individual perceptions of the 
neighborhood stressors may be more closely related to individual changes in diurnal cortisol 
patterns than an aggregated measure of perceived stress from multiple neighborhood residents. 
Thus, it may be more appropriate to treat each of these scales or even the composite perceived 
neighborhood stress measure as an individual-level covariate rather than a true neighborhood-
level variable. 
 While findings from the MESA Stress Study and CCAHS provide an interesting first 
look at the relationships among individual-level stress, neighborhood-level stressors, and diurnal 
cortisol patterns, many questions still remain. Of particular importance to the conceptual model 
developed in Chapter 2 and the findings reported in Chapter 3 is the question of how individual-
and neighborhood-level sociodemographic factors may shape individual’s exposure to the 
stressors. More specifically, do minority residents who live in neighborhoods with a greater 
percentage of co-ethnic minorities exhibit less dysregulated cortisol profiles, net of objective 
neighborhood-level socioeconomic factors? If so, can this relationship be at least partially 
explained lower levels of perceived unfair treatment?  
 The purpose of this study is to examine contextual factors (i.e., individual 
sociodemographic characteristics, neighborhood sociodemographic characteristics) which may 
be associated with: 1) individual perceptions of acute and everyday unfair treatment, 2) average 
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daily decline in salivary cortisol levels, and 3) the potential relationship between perceived unfair 
treatment and daily salivary cortisol decline. To begin addressing these issues, I use data from 
the Healthy Environments Partnership (HEP) Wave 2 Community Survey and the 
Race/Ethnicity, Psychosocial and Environmental Stressors, and Telomere Length examine 
potential individual- and neighborhood-level covariates of cortisol dysregulation.  
 
 
Methods 
Data Sources 
 Data for this analysis came from three sources. Information regarding individual-level 
sociodemographics and perceived unfair treatment were collected as part of the Health 
Environments Partnership (HEP) Wave 2 Community Survey. The HEP Wave 2 Community 
Survey was conducted in 2008 as a follow-up to the initial survey launched in 2002. The first 
HEP survey was a stratified two-stage probability sample of Detroit residents living in one of 
three areas that were chosen for their relative sociodemographic diversity (Schulz et al., 2005). 
The 2008 Wave 2 survey attempted to re-contact original survey respondents and collect 
additional information regarding their perceptions of the neighborhood physical and social 
environment, stressful experiences, physical activity, other health behaviors, and current 
cardiovascular health status. Of the 919 Wave 1 HEP Community Survey participants, 219 were 
successfully enrolled into the Wave 2 survey. An additional 241 residents living on the same 
block as unreachable respondents from the Wave 1 survey were enrolled into the study, for a 
total of 460 participants. 
 Salivary cortisol samples were collected from a subset of the HEP Wave 2 Community 
Survey participants as part of the Race/Ethnicity, Psychosocial and Environmental Stressors, and 
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Telomere Length study, which will subsequently be referred to as the Telomere Study. The 460 
HEP Wave 2 participants represent the universe of eligible individuals for the Telomere Study. 
During the course of the HEP Wave 2 interview, participants were given a brief overview of the 
Telomere Study aims, participation requirements, and payment for study participation. If the 
HEP Wave 2 participant indicated that he or she was interested in learning more about the 
Telomere Study, their contact information was forwarded to the Telomere Study assistant project 
director for follow-up. Of the 262 HEP Wave 2 participants who were contacted by the assistant 
project director and expressed interest Telomere Study enrollment, 241 individuals completed 
the study interview and provided either blood (n = 2), saliva (n = 12), or both blood and saliva (n 
= 227) samples for analysis. Because the cortisol levels were obtained via saliva samples, the 
two participants who only provided blood samples were ineligible for the current analysis.  
 Finally, Telomere Study participants’ street addresses were used to geocode the data set 
and link it to the 2010 U.S. Census block group definitions for the city of Detroit. Block groups 
are used to represent each participant’s neighborhood of residence at the time of their enrollment 
in the Telomere Study.  Between the time of the HEP Wave 2 survey and enrollment into the 
Telomere Study, five participants moved from a block group that was within one of the three 
HEP-defined study areas (i.e., Eastside, Northwest, or Southwest Detroit) to a block group that 
was outside of the study area boundaries. These participants were excluded from the current 
analyses, as the answers that they provided during the HEP Wave 2 survey reflect different 
neighborhoods than those in which they were living in at the time of the Telomere Study’s 
cortisol sample collection. Following the merger of the HEP Wave 2 survey, Telomere Study 
cortisol results, and 2010 Census block group data, the total of 234 individuals were initially 
eligible for this study.  
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 The Telomere Study was approved by the University of Michigan Health Sciences and 
Behavioral Sciences Institutional Review Board and the HEP Steering Committee. Members of 
the HEP Steering Committee’s Data Use Subcommittee reviewed the proposal for the current 
analysis and granted permission for the secondary use of their data set. 
 
Cortisol collection & measurement 
  Approximately four to seven days prior to their Telomere Study clinic appointment or 
home visit, enrolled participants received a set of nine numbered saliva collection tubes. On the 
three weekdays immediately prior to their scheduled clinic appointment or home visit, 
participants were instructed to remove the cotton roll from the sequentially numbered tubes, 
chew on the cotton roll for approximately one minute, return the cotton roll to the tube without 
touching the cotton, and record the time of the sample collection on the sheet provided. The 
instructions also specified that the saliva collection should take place at three particular time 
points on each of the three days: immediately after waking up and before getting out of bed; 30 
minutes after waking up and before eating, brushing teeth, or smoking; and immediately before 
going to bed in the evening, at least 30 minutes after eating, brushing teeth, or smoking. The set 
of nine saliva collection tubes were returned to the assistant project director during the clinic 
appointment or home visit. All samples were logged and stored at -80 ºC in the Central Ligand 
Assay Satellite Services (CLASS) laboratory of the University of Michigan School of Public 
Health until being shipped on dry ice to the University of Trier Psychobiology Laboratory for 
analysis. The laboratory’s salivary cortisol assay procedures are described in detail elsewhere 
(Dressendorfer, Kirschbaum, Rohde, Stahl, & Strasburger, 1992).  Each cortisol sample was run 
in duplicate and the intra-assay coefficients of variation (CV) were recorded. The laboratory 
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received no identifying or sociodemographic information about the participants and provided 
results linked to the unique randomly-generated identification number assigned to each 
participate upon enrollment in the Telomere Study. 
  As illustrated in Figure 1-1 and described in Kudielka et al (2012), cortisol secretion 
occurs in a time dependent, pulsatile pattern over the course of 24-hour period. While other 
studies have examined multiple components of this daily pattern, I chose to focus on the daily 
cortisol decline for four reasons. First and foremost, the decline in cortisol levels over the course 
of the day – sometimes referred to as the diurnal slope – is thought to be less dependent on the 
circadian light cycle than the post-waking rise in cortisol levels, commonly referred to as the 
cortisol awakening response or CAR (Kudielka et al., 2012). Thus, measuring the daily decline 
in cortisol values from wake-up to bedtime excluding the CAR should yield a measure that is 
less prone to bias related to circadian control (Smyth, Hucklebridge, Thorn, Evans, & Clow, 
2013), differences between workdays and non-workdays (Schlotz, Hellhammer, Schulz, & 
Stone, 2004) , and error introduced by mistimed sample collection (Smyth, Clow, Thorn, 
Hucklebridge, & Evans, 2013).  In addition, recent work has noted that while there is still 
considerable intra-individual variation over long periods of time, daily cortisol decline is more 
stable than the CAR (Ross, Murphy, Adam, Chen, & Miller, 2014), is more closely related to 
other aspects of the diurnal cortisol pattern (Clow, Hucklebridge, Stalder, Evans, & Thorn, 2010; 
Golden et al., 2013), and is more conceptually relevant to the biological assessment of chronic 
stress exposure (Hellhammer, Wüst, & Kudielka, 2009). Perhaps owing to this increased intra-
individual stability and conceptual relevance, previous empirical findings related to 
sociodemographic characteristics have been most consistent when examining patterns of daily 
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cortisol decline rather than other aspects of the diurnal pattern (i.e., waking levels, bedtime 
levels, or CAR) (Dowd et al., 2009). 
  While no professional societies have established precise guidelines, several review papers 
have set forth basic principles for the collection and analysis of salivary cortisol samples 
(Hellhammer et al., 2009; Kudielka et al., 2012; Smyth, Hucklebridge, et al., 2013). Following 
these recommendations, participants were excluded from the analysis if, on all three study days, 
the wake-up saliva sample was collected before 4 AM or after 11 AM. Participants were also 
excluded if all three days of bedtime saliva samples were collected less than 12 hours or more 
than 20 hours after the wake-up sample. Together, these saliva sampling time criteria resulted in 
the removal of 9 participants from the analysis (see Table 4-1). 
 To estimate the daily cortisol decline in this study, the waking cortisol level was 
subtracted from the bedtime cortisol level and divided by the number of hours between the two 
sample collection times. This process was repeated for each available day of eligible cortisol 
data. Of the 184 eligible participants, 124 (67.4%) had valid daily cortisol decline data for all 
three sampling days. Forty-eight participants (26.1%) had valid cortisol data for 2 of the 3 
sampling days, with the remaining 12 participants (6.5%) only having a valid daily cortisol 
decline for one sampling day.  Following a range check of the otherwise eligible cortisol data, 
one participant was removed from the analysis due to intra-assay coefficient of variance values 
greater than 20% and three participants were removed due to cortisol values that were both 
greater than three standard deviations above the study’s mean and outside the expected 
physiological range. All remaining available daily cortisol decline data were used to create an 
individual-specific mean daily cortisol decline measure. This measure served as the primary 
outcome measure representing individual-level biological stress response.  
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 Other studies have used more complex models such as multilevel linear splines to 
approximate the daily cortisol decline (Karb et al., 2012; Sanchez, Wu, Raghunathan, & Diez-
Roux, 2012). However, that approach requires setting at least one knot for the splines. Given that 
the Telomere Study only collected saliva at three time points across the day, and that the second 
time point was selected to measure the CAR, using a multilevel linear spline approach would 
have required incorporating the CAR into the daily cortisol decline model.  I chose not to use this 
approach given the prior discussion regarding the potential for CAR and daily cortisol decline to 
be subject to different source of physiologic regulation. This decision follows the precedent set 
by DeSantis, et al (2007). 
 Even if one or more additional cortisol measures were available in the Telomere Study, 
the only day-specific information that was collected was the time of the saliva sample. As such, 
adding a third, collection day-specific level nested within the current two-level regression model 
would have yielded only one additional covariate (i.e., collection time) to address the intra-
individual variation in daily cortisol decline. Fortunately, Kraemer and colleagues (2006) found 
that the daily cortisol decline calculated from two cortisol measures (wake-up and evening) were 
highly correlated with a four sample measure of daily cortisol decline. Based on their findings 
and to reduce bias related to the previously discussed CAR, issues the 30 minute post-awakening 
samples were excluded from the slope calculation.  
 
Demographic and survey measures  
Perceived unfair treatment 
 Previously validated measures of everyday and acute unfair treatment were used  in the 
HEP Wave 2 survey, with some minor modifications (Williams, Yu, Jackson, & Anderson, 
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1997). The acute unfair treatment scale ascertained whether participants had experienced unfair 
treatment in one of seven domains within the past 12 months: unfair treatment at work, from 
police or immigration officials, at school, while getting housing or other resources, while seeking 
health care, or while obtaining other services. One point was assigned for each affirmative 
response. The scores from the seven items were summed and then divided by seven to yield a 
possible maximum score of 1. Because acute unfair treatment is central to the study questions, 
the two individuals who did not respond to this portion of the survey were excluded from the 
analyses. 
 The everyday unfair treatment measure asked participants to report, on a 5-point scale from 
“never” to “always,” how frequently they experienced five less severe interactions: being treated 
with less courtesy or respect, receiving poorer service, being treated as if not smart, acting afraid 
of you, or feeling threatened or harassed.  Scores from the five items were summed and divided 
by five to yield a range of scores from 0 to 5. 
 
Individual-level sociodemographics 
 Race/ethnicity. Due to the hypothesized importance of the relationship between 
individual race/ethnicity and neighborhood racial/ethnic composition, the analysis will be limited 
to participants who report their racial/ethnic background as non-Hispanic white, non-Hispanic 
black, or Hispanic. Two individuals who reported their race to be “Other, non-Hispanic” and one 
individual of an unspecified multiracial background were excluded from the study. 
 Gender. Previous studies have been inconsistent, as some report flatter daily cortisol 
declines among females (Hajat et al., 2010; Karb et al., 2012), others report males are worse off 
(Karlamangla et al., 2013; Kumari et al., 2010), and still others have found no significant gender 
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differences (DeSantis et al., 2007; Skinner et al., 2011). Nevertheless, gender is included in the 
models. 
 Age was operationalized as a continuous variable. Previous research has indicated that the 
daily cortisol decline is flatter with increasing age (Karlamangla et al., 2013; Kumari et al., 2010; 
Nater, Hoppmann, & Scott, 2013), therefore age was controlled for in all analyses. 
 Poverty-to-income ratio (PIR) was dichotomized, with participants reporting an annual 
household income level below that of the federal, household size-adjusted poverty level (i.e., PIR 
< 1) as the group of interest. Twenty-one participants were excluded from the analysis due to 
missing data PIR data.   
 Highest level of education was divided into four categories: less than a high school 
degree, high school degree or GED, some college or an associate’s degree, and college degree or 
higher. Four participants reported “other” as their highest level of education and were excluded 
from this analysis. 
 
Neighborhood-level sociodemographics  
 Neighborhood racial/ethnic concentration was measured for non-Hispanic whites, non-
Hispanic blacks, and Hispanics of all racial backgrounds at the census block group level using 
data from the 2007-2011 American Community Survey estimates. The 5-year period of the ACS 
data set completely encompasses the Telomere Study data collection period (2008-2010), as well 
as the recent recession and housing crises.  
 Neighborhood socioeconomic status was assessed using the percentage of block group 
households with a poverty-to-income ratio (PIR) of less than one. This is the same type of SES 
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measure that was used at the individual level, but was derived from the 2007-2011 ACS 
estimates rather than an aggregation of the individual-level data from HEP participants residing 
within the same block group. 
   
Potential confounders of the stress-cortisol relationship 
 Current medications. Given prior research linking variation in cortisol levels to steroid 
medications (Granger, Hibel, Fortunato, & Kapelewski, 2009), I examined current medication 
usage as reported during the Telomere Study interview. The medication listings were reviewed 
and dichotomized as currently taking / not currently taking steroid medications. Seven 
participants were removed from the analysis due to report of their self-report of currently taking 
a corticosteroid medication that could influence the salivary cortisol measurement. 
 Body mass index (BMI) has also been associated with cortisol secretion (Ranjit, Young, 
Raghunathan, & Kaplan, 2005). However, BMI may also be associated with stress via a number 
of mechanisms including stress-related eating (Torres & Nowson, 2007) or reduced physical 
activity (Moore-Greene, Gross, Silver, & Perrino, 2012).  BMI was thus included in the 
regression models, and was coded into the three standard categories of normal (< 25), overweight 
(25-29.9), or obese (≥ 30).     
 Finally, smoking has been previously associated with flatter daily cortisol declines 
(Kumari et al., 2010), and is frequently considered to be stress-related health behavior (Cohen et 
al., 2006; Ranjit et al., 2005). To account for the potential confounding relationships, HEP 
survey measures of current smoking status (yes/no/former smoker) was used to account for 
individual level variation in tobacco use.  
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Sample Demographics  
 The final sample for this study consisted of 184 participants living within one of 49 
census block groups in the three HEP study areas. A summary of the various exclusion criteria 
and the number of HEP Wave 2 participants omitted from the analysis can be found in Table 4-1. 
 The basic demographics of the study sample are reported in Table 4-2.   Reflecting the 
recent economic challenges facing many Detroiters, the nearly half of our sample reported 
annual household incomes that are below the federal poverty level, adjusted for household size. 
The almost uniformly disadvantaged socioeconomic status of the study population across 
racial/ethnic groups may have important implications for the interpretation and generalizability 
of the study results. 
 Compared to those with complete data on all measures, cortisol-eligible individuals who 
were missing data on one of the key covariates reported significantly lower levels of both acute 
(0.12 vs. 0.24; p = 0.02) and everyday unfair treatment (1.47 vs. 1.87; p < 0.01). Individuals with 
missing data were also somewhat more likely to be Hispanic (23.4% of individuals with missing 
data vs. 9.4% of the study population; p = 0.07) and to have a flatter daily cortisol decline (-
0.255 vs. -0.393; p = 0.07). These differences between the included and excluded participants 
could introduce bias into the study findings. 
 
Analysis 
 Descriptive statistics, univariate regression models, multivariate linear regression models, 
used to assess the patterning of perceived acute and everyday discrimination within the study 
population. To maximize the available multi-day cortisol data and provide a more nuanced 
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analysis of contextual factors at both the individual- and neighborhood-level, I used two-level 
random coefficient models, nesting individuals within block groups with the xtmixed command 
in Stata 13.  
 
 
Results 
 
Everyday unfair treatment as an outcome 
 As anticipated, black participants reported significantly higher levels of everyday unfair 
treatment relative to whites. Everyday unfair treatment levels were highest and most statistically 
significant among black participants with poverty-to-income ratios above 1. Hispanic 
participants also reported higher levels than whites but lower levels than black participants. 
Neither the Hispanic-white nor the Hispanic-black differences reached statistical significance 
 In multivariate models, higher everyday unfair treatment levels were associated with 
younger age, being male, and having a college degree. The ICC for the fully adjusted individual-
level models indicate that almost 9% of the variation in everyday unfair treatment was 
attributable to variation at the block group level. Block group-level racial/ethnic concentration 
and SES, as measured by the percentage of households with PIR < 1, were not associated with 
everyday unfair treatment. However, including either the percentage of black neighborhood 
residents or the percentage of white neighborhood residents modestly reduced the statistical 
significance of the difference between black and white participants. 
 
Acute unfair treatment as an outcome 
 Surprisingly, descriptive statistics indicated that there was no statistically significant 
difference in levels across racial/ethnic groups. In multivariate models, higher acute unfair 
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treatment levels were associated with being male and having a college degree. In the fully 
adjusted individual-level models, 13% of the variation in acute unfair treatment was attributable 
to variation at the block group level. Neither block group percentage of black residents, 
percentage of Hispanic residents, nor block group SES were associated with acute unfair 
treatment. However, the block group percentage of white residents was significantly and 
negatively associated with acute unfair treatment. The addition of percent white residents also 
reduced the variation in acute unfair treatment attributable to block group-factors from 13% to 
8%. 
 
Daily cortisol decline 
 The mean daily cortisol decline was significantly less among Black participants. In 
exploratory analyses that subdivide white, black, and Hispanic participants by PIR level, the 
relationship with daily cortisol decline appears to be strongest among black participants with PIR 
< 1. Hispanic participants also significantly flatter daily cortisol decline compared to whites, but 
it is still greater than the mean decline among blacks. 
 In multivariate models, lower daily declines in cortisol levels were associated with older 
age, having a high school degree (relative to having a college degree), being a current smoker, 
and reporting higher levels of everyday unfair treatment. Reporting higher levels of acute unfair 
treatment also had a modest but consistent effect throughout out the models. 
 Adding block group-level variables to the model yielded several statistically significant 
results. First, higher percentages of neighborhood households with PIR < 1 was associated with a 
less steep mean daily cortisol decline. The addition of black neighborhood racial concentration 
resulted in a more complex set of relationships. Overall, higher percentages of black 
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neighrbohood residents were associated with a significantly less steep daily cortisol decline. 
However, the decrease in the magnitude of the cofficient for black study participants indicates 
that, when black neighborhood racial concentration is incorporated into the model, the black-
white difference in mean daily cortisol decline becomes smaller, yet is still statistically 
significant (Table 4-5, model 5 vs. model 6). In addition, the coefficient for acute life events is 
not statistically significant once the neighborhood percentage of black residents is added to the 
model. Incorporating the percentage of Hispanic neighborhood residents has the opposite result, 
as higher percentages of Hispanic residents are associated with greater mean daily cortisol 
declines (Table 4-5, model 7). Again, the coefficients for both black and Hispanic study 
participants are attenuated in with the addition of this neighborhood composition measure, but 
they are still significantly different from whites. The percentage of white residents had no 
significant effect on daily decline, nor on other covariates within the model. In the full 
individually-adjusted model, the amount of block group attributable variation in cortisol daily 
decline was nearly 14%. Adding the block group –level covariates reduced this figure to ~9% 
 
 
Discussion 
 The sociodemographic patterning of everyday and acute unfair treatment is similar in 
terms of gender and education, but differs with respect to the associations with individual 
race/ethnicity, depressive symptoms, and block group percentages of white residents. The flatter 
mean daily cortisol decline observed among black participants may be an indicator of biological 
stress response dysregulation and/or greater levels of cortisol exposure throughout the day. Each 
of these underlying affects may be detrimental to one’s health. 
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 One counterintuitive finding is that while individuals with a college education and black 
participants with higher PIR report higher levels of unfair treatment, they also have more robust 
or “healthier” daily cortisol declines. While these two findings may not be causally related to one 
another, it is possible that having additional financial or other forms of supportive resources 
associated with having a college education or higher PIR help mitigate the otherwise detrimental 
biopsychosocial effects of perceived unfair treatment. It is also possible that the relationship 
could work in the opposite direction: having greater access to various resources associated with 
higher levels of education or PIR may also lead to a more conscious understanding of unfair 
treatment when it occurs, and as such, more active and effective coping with the situation. 
 Finally, the measured neighborhood sociodemographic features are of greater statistical 
significance to daily cortisol declines than the two unfair treatment measures. This suggests that 
there may be unexplored aspects of the neighborhood social or physical environment that are 
both related to neighborhood socioeconomic status and/or racial composition and diurnal cortisol 
patterns. Post-hoc exploratory analyses of several types of neighborhood perceptions, including 
sense of community, neighborhood social environment, neighborhood physical environment, and 
neighborhood satisfaction yielded largely non-significant findings. The one exception was a five-
item measure assessing negative aspects of the neighborhood social environment, including gang 
activity and loitering: higher scores on this measure were associated with flatter daily cortisol 
decline. Additional exploration of this and other perceptions of the neighborhood environment 
may identify actionable aspects of the neighborhood environment that could improve diurnal 
cortisol patterns and potentially improve residents’ health. 
 There are several limitations to this study, starting with the small sample size. With less 
than 40 participants in the white and Hispanic subpopulations, the stratified sub-analyses lack the 
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power to detect more subtle predictors of unfair treatment and daily cortisol decline. In addition 
to the small sample size, there are several limitations to conducting a post-hoc, cross-sectional 
analysis. First, there non-random sources of measurement error could have been introduced via 
the cortisol assay process. While all samples were collected in the same manner and were 
analyzed by the same laboratory using standard protocols, the samples varied in the length of 
time they were frozen prior to analysis, with the Day 3 samples remaining in storage for the 
longest period of time. This issue is partially addressed by averaging of the cortisol values across 
all eligible study days. There was also a varying degree of lag time between the completion of 
the HEP Wave 2 survey and the collection of the saliva samples as part of the Telomere Study. 
This lag time ranged from less than a month to nearly two years, with the average time between 
survey completion on saliva collection being 6 months. Given the recently-published evidence 
regarding the modest intra-individual correlation of repeated daily cortisol decline measures, the 
results described in this paper could be strengthened if the cortisol and survey measurements 
were completed at the same time (Ross et al., 2014). 
 Second, as is the case in most secondary data analyses, the measures that are available 
from the combined HEP-Telomere data set may not be the optimal measures of the constructs of 
interest within the conceptual model that is guiding the analysis. The HEP Wave 2 survey did 
use slightly modified versions of two previously-validated measures of unfair treatment, but 
these measures only capture the perceived or acknowledged occurrence of specific events. As 
with other stressors, individuals may be subjected to unfair treatment and have a physiological 
response to the unfair treatment even if they do consciously acknowledge the discrimination for 
what it is. Other researchers have posited that recognizing and actively coping with experiences 
of racial discrimination may help reduce its deleterious psychological effects (Williams & 
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Mohammed, 2009). Moreover, recent work by Hicken and colleagues suggests that the 
anticipation of  race-related discrimination is associated with hypertension prevalence (Hicken, 
Lee, Morenoff, House, & Williams, 2014) and sleep difficulty (Hicken, Lee, Ailshire, Burgard, 
& Williams, 2013) among blacks. When considering the circadian influences on cortisol release 
and the previously described relationship between flattened daily cortisol decline and 
hypertension, one could make the argument that the modest association between acute unfair 
treatment and daily cortisol decline may belie a potentially more important relationship between 
race-related vigilance and daily cortisol decline.  
 Finally, within the broader context of the conceptual model presented in Chapter 2, this 
population and study design does not allow for a more direct test of the relationship between 
cortisol dysregulation and subtype-specific breast cancer risk. A much larger, prospective study 
would be necessary to adequately assess that potential relationship. The combined results from 
my studies may, at best, merely suggest that this proposed pathway be explored further. 
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Table 4-1: Summary of study exclusion criteria and final sample size 
Total number of HEP 2008 Community Survey participants: 460 
Number of participants excluded based on the following criteria:  
Did not participate in the Telomere study 222 
Home address at the time of saliva collection was outside of the HEP study areas 5 
Key variables with incomplete data (unfair treatment, PIR) or designated as “other” (race/ethnicity, education)  30 
Did not meet one or more of the saliva sample collection standards on all 3 collection days 9 
Unreliable or unrealistic cortisol values for all 3 collection days 3 
Self-report of relevant steroid medication usage during the past week 7 
Total number of eligible participants: 184 
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Table 4-2: Participant characteristics 
 
 Full sample:    White:     Black:  Hispanic: 
Number of respondents (% of total) 184 38 (20.7%) 103 (56.0%) 43 (23.4%) 
Mean age (SD) 49.7 (12.1) 54.8 (12.5) 50.1 (11.0) 44.2 (12.5) 
Sex: 
      Female (%) 131 (71.2%) 25 (65.8%) 77 (74.8%) 29 (67.4%) 
  Male (%)   53 (28.8%) 13 (34.2%) 26 (25.2%) 14 (32.6%) 
Poverty-to-income ratio < 1 (%)   88 (47.8%) 19 (50%) 49 (47.6%) 20 (46.5%) 
Highest education level: 
      Less than high school degree (%)  57 (31.0%) 13 (34.2%) 22 (21.3%) 22 (51.2%) 
  High school degree or GED (%)   46 (25.0%)   5 (13.2%) 31 (30.1%) 10 (23.3%) 
  Some college (%)   63 (34.2%) 12 (31.6%) 42 (40.8%)   9 (20.9%) 
  College degree or higher (%)   18 (9.8%)   8 (21.1%)   8 (7.8%)   2 (4.7%) 
Smoking status: 
      Never smoked (%)  73 (39.7%) 12 (31.6%) 38 (36.9%) 23 (53.5%) 
  Current smoker (%)   59 (32.1%) 14 (36.8%) 38 (36.9%)   7 (16.3%) 
  Former smoker (%)   52 (28.3%) 12 (31.6%) 27 (26.2%) 13 (30.2%) 
Body mass index (BMI): 
      Normal (18.0 - 24.9) (%)  32 (17.4%)  8 (21.1%) 22 (21.4%)  2 (4.7%) 
  Overweight (25.0 - 29.9) (%)   50 (27.2%)   9 (23.7%) 29 (28.2%) 12 (27.9%) 
  Obese (>= 30) (%) 102 (55.4%) 21 (55.3%) 52 (50.5%) 29 (67.4%) 
Current medication usage: 
      Using psychotropic medication (%)  11 (6.0%)  6 (15.8%)  5 (4.9%)  0 
  Using HRT or oral contraceptives (%)     4 (2.2%)   2 (5.3%)   2 (1.9%)   0 
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Table 4-3: Block group characteristics 
 
 Full sample:    White:     Black:  Hispanic: 
Number of respondents (% of total) 184 38 (20.7%) 103 (56.0%) 43 (23.4%) 
Number of unique block groups 49 18 39 14 
Mean % of block group with PIR < 1 (SD) 44.7% (17.9) 49.3% (14.7) 43.8% (19.1) 44.0% (14.9) 
Block group (BG) racial/ethnic composition: 
      Mean % BG non-Hispanic white alone (SD)  9.9% (10.1) 16.2% (8.3)  9.1% (10.0) 15.9% (10.6) 
  Mean % BG non-Hispanic black alone (SD) 69.2% (35.6) 38.0% (38.5) 77.4% (28.5) 21.8% (31.0) 
  Mean % BG Hispanic (SD) 18.8% (31.1) 44.5% (38.1) 11.2% (22.5) 60.7% (29.5) 
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Table 4-4: Unadjusted distribution of key variables across racial/ethnic groups 
 
  Full sample:      White:       Black:    Hispanic: 
Number of respondents (% of total)    184   38 (20.7%)   103 (56.0%)   43 (23.4%) 
Mean # depressive symptoms (SD)    2.72 (0.52)   2.71 (0.51)   2.73 (0.54)   2.69 (0.48) 
Unfair treatment / discrimination: 
         Mean acute unfair treatment (SD)    0.24 (0.26)   0.23 (0.22)   0.28 (0.28)   0.17 (0.21) 
     Mean everyday unfair treatment (SD)    1.87 (0.69)   1.66 (0.49)   1.97 (0.72)   1.81 (0.74) 
Diurnal cortisol measures, nmol/L: 
         Mean wake-up cortisol level (SD)  10.17 (6.09) 12.68 (6.72)   9.19 (6.47) 10.28 (3.42) 
     Mean bedtime cortisol level (SD)    4.46 (4.41)   4.11 (5.30)   5.09 (4.57)   3.26 (2.61) 
     Mean hourly cortisol decline (SD)  - 0.39 (0.40) - 0.62 (0.45) - 0.27 (0.38) - 0.49 (0.28) 
* Bolded statistics indicate unadjusted, statistically significant difference from white participants’ results (p ≤ 0.05) 
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Table 4-5: Two-level models of mean hourly decline in salivary cortisol levels & acute unfair treatment (n = 184) 
 Model 1 Model 2 Model 3 Model 4 Model 5 Model 6 Model 7 Model 8 
Level 1 coefficients         
Race: [ref = White]         
Black  0.336** 0.318** 0.325** 0.338** 0.227** 0.213** 0.347** 
Hispanic  0.150^ 0.149^ 0.192* 0.196* 0.229** 0.238** 0.194* 
Poverty-to-Income Ratio < 1   -0.050  -0.047  -0.047  -0.045  -0.034  -0.026  -0.045 
Age (in years)  0.004^ 0.004 0.003 0.002 0.002 0.002 0.002 
Female  0.011 0.034 0.061 0.068 0.072 0.079 0.069 
Education: [ref = college]          
Less than high school  0.214* 0.260* 0.188^ 0.148 0.131 0.130 0.150 
High school degree / GED  0.248* 0.297** 0.236* 0.208* 0.195^ 0.193^ 0.209* 
Some college  0.138 0.157 0.116 0.079 0.072 0.063 0.079 
Acute unfair treatment   0.213^ 0.196^ 0.190^ 0.172 0.178^ 0.194^ 
Smoking status: [ref = never]         
Current smoker    0.151* 0.166* 0.181** 0.180** 0.164** 
Former smoker    0.091 0.095 0.095 0.093 0.095 
BMI: [ref = normal]         
Overweight     -0.009  -0.018  -0.006  -0.002  -0.019 
Obese    0.070 0.066 0.074 0.082 0.067 
Level 2 coefficients         
% residents with PIR < 1     0.005** 0.004** 0.004** 0.005** 
% Black residents      0.003*   
% Hispanic residents        -0.003**  
% White residents        0.001 
Residual variance,  ̂ 0.135 0.121 0.119 0.112 0.110 0.107 0.108 0.111 
Conditional variance,  ̂ 0.025 0.013 0.013 0.016 0.012 0.011 0.009 0.011 
Composite error,  ̂ 0.160 0.134 0.132 0.128 0.122 0.118 0.117 0.122 
ICC 0.158 0.096 0.095 0.128 0.097 0.094 0.075 0.091 
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Table 4-6: Two-level models of mean hourly decline in salivary cortisol levels & everyday unfair treatment (n = 184) 
 Model 1 Model 2 Model 3 Model 4 Model 5 Model 6 Model 7 Model 8 
Level 1 coefficients         
Race: [ref = White]         
Black  0.336** 0.317** 0.325** 0.337** 0.218* 0.205* 0.340** 
Hispanic  0.150^ 0.146^ 0.187* 0.188* 0.224** 0.232** 0.188* 
Poverty-to-Income Ratio < 1   -0.050  -0.049  -0.049  -0.047  -0.035  -0.026  -0.047 
Age (in years)  0.004^ 0.004^ 0.004 0.003 0.003 0.003 0.003 
Female  0.011 0.025 0.051 0.059 0.065 0.072 0.059 
Education: [ref = college]          
Less than high school  0.214* 0.232* 0.160 0.123 0.109 0.108 0.123 
High school degree / GED  0.248* 0.254* 0.195^ 0.170 0.161 0.158 0.170 
Some college  0.138 0.151 0.108 0.073 0.067 0.058 0.073 
Everyday unfair treatment   0.068^ 0.057 0.060 0.061 0.063 0.060 
Smoking status: [ref = 
never] 
        
Current smoker    0.148* 0.163* 0.178** 0.177** 0.162* 
Former smoker    0.097 0.099 0.099 0.097 0.100 
BMI: [ref = normal]         
Overweight     0.005 0.005 0.009 0.013  -0.005 
Obese    0.075 0.072 0.080 0.088 0.072 
Level 2 coefficients         
% residents with PIR < 1     0.005** 0.005** 0.005** 0.005** 
% Black residents      0.003**   
% Hispanic residents        -0.004**  
% White residents        0.000 
Residual variance,  ̂ 0.135 0.121 0.118 0.112 0.111 0.108 0.108 0.111 
Conditional variance,  ̂ 0.025 0.013 0.014 0.017 0.012 0.011 0.008 0.012 
Composite error,  ̂ 0.160 0.134 0.132 0.129 0.123 0.119 0.116 0.123 
Residual interclass 
correlation 
0.158 0.096 0.103 0.132 0.096 0.091 0.072 0.094 
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Figure 4-1: Predicted mean cortisol levels, by gender and race/ethnicity  
  
Margins set for high school graduate, non-smokers with a normal BMI and mean values for all other covariates 
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Figure 4-2: Predicted mean cortisol levels, by gender, race/ethnicity, and PIR status 
  
Margins set for high school graduate, non-smokers with a normal BMI and mean values for all other covariates
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Chapter 5 
Conclusions 
 
The triple-negative subtype of breast cancer is etiologically and clinically distinct from 
the more common, less aggressive, and more treatable form of estrogen receptor-positive breast 
cancer. Numerous population-based studies have found that black women are 2 to 3 times more 
likely to develop triple-negative breast cancer than white women. Much of the existing research 
on racial disparities in breast cancer subtype has focused on identifying predisposing biological 
or genetic factors associated with African ancestry. However, this approach ignores growing 
multidisciplinary evidence suggesting that contemporary racial stratification shapes a wide range 
of environmental and social exposures that can subsequently impact cellular physiology and even 
gene expression patterns.  
Chapter 1 of this dissertation introduces how a multidisciplinary, multilevel framework 
rooted in current empirical evidence and structurally oriented theory may provide some new 
insight into the persistence of racial/ethnic disparities in breast cancer subtype.  Chapter 2 greatly 
expands upon this argument via the synthesis and critique of current evidence regarding subtype-
specific breast cancer epidemiology, the purported role of African ancestry as a breast cancer 
risk factor, and potential relationships between stress and breast cancer risk. With this evidence 
in mind, I then introduce several theoretical perspectives that guide the integration of the 
empirical data into a new conceptual model of the potential origins of racial/ethnic disparities in 
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breast cancer subtypes. Among the various theories, Geronimus’ weathering hypothesis provides 
a particularly useful analytic framework through which to consider how psychosocial and 
environmental stressors may structure the disruption of biological mechanisms according to race. 
Building upon this framework, I suggest that the ways in which structural forces shape 
neighborhood social environments may play an important – and as of yet untested – role in the 
biopsychosocial pathways that could ultimately impact gene expression patterns. Specific 
alterations in gene expression patterns may subsequently increase the risk of the more aggressive 
forms of breast cancer that are more prevalent among black American women.  
I begin testing parts of the conceptual model in Chapter 3. Using data from the California 
Cancer Registry, the California Neighborhood Data System, and the 2000 U. S. Census, I 
identified significant variation in the odds of ER-/PR- breast cancer across racial/ethnic groups. 
More importantly, I found that the racial/ethnic groups also vary in terms of how neighborhood 
socioeconomic status and racial/ethnic concentration relate to ER-/PR- odds ratios, and that this 
neighborhood level patterning itself varies between highly segregated and less segregated 
metropolitan areas. While white women in every segregation and age group strata have lower 
odds of ER-/PR- breast cancer with increasing neighborhood socioeconomic status (SES), only 
younger black women appear to benefit from higher levels of neighborhood SES. Conversely, 
while black women as a whole had significantly lower odds of ER-/PR- breast cancer when 
living in neighborhoods with a higher percentage of black residents, this relationship was 
statistically significant only among older black women when the group was stratified by age at 
diagnosis. These findings indicate that much more work needs to be done in order to unpack the 
complex relationships among age (as it relates to both neighborhood tenure and more general life 
course phases), neighborhood characteristics (particularly the interplay between residential 
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stability and neighborhood sociodemographics), and biopsychosocial pathways that facilitate the 
observed association between neighborhood characteristics and odds of having a more 
aggressive subtype of breast cancer. 
In Chapter 4, I begin to explore one potential biopsychosocial pathway that could link 
race-related stressors to racial variation in odds of being diagnosed with an ER-/PR- breast 
cancer. Previous work suggests that exposure to chronic stressors within racially and 
economically segregated residential neighborhoods may contribute to dysregulation of the 
cortisol feedback loop (Do et al., 2011; Karb, Elliott, Dowd, & Morenoff, 2012). Recent work by 
Ritter, Antonova, and Mueller (2012) suggests that dysregulation of the stress-mediated cortisol 
feedback loop reduces the expression of the critical tumor suppressor gene, BRCA1.  Current 
evidence suggests that there are several molecular pathways by which loss of BRCA1 function 
may lead to the TNBC subtype (Santarosa & Maestro, 2012). It is therefore plausible that 
dysregulation of the stress-mediated cortisol feedback loop could increase the risk of developing 
TNBC via the cumulative impact of decreased BRCA1 expression.  
In order to examine the relationships among perceived unfair treatment, neighborhood 
sociodemographic features, and daily cortisol decline, I conducted a multilevel of analysis of 
daily cortisol decline among residents of three Detroit areas. The results of this study suggest that 
perceived acute unfair treatment may have a modest association with flatter – presumably less 
well-regulated and thus less healthy – diurnal cortisol patterns. Neighborhood socioeconomic 
status and racial/ethnic concentration may also be related to variation in daily cortisol decline, 
but perhaps not in the direction that was expected based on the findings of my first empirical 
paper or prior salivary cortisol research. 
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Taken together, this work is just the beginning of an interdisciplinary, contextual 
examination of the potential social and biological mechanism that link institutional racism to risk 
of specific breast cancer molecular subtypes. Future steps in building this area of research may 
include: the study of longitudinal, nuanced residential histories in terms of exposure to racially 
structured psychosocial exposures and subtype-specific breast cancer incidence; gene-
environment correlation studies that  incorporate single nucleotide polymorphisms (SNPs) 
associated with specific breast cancer subtypes into analyses of race-related social exposures; 
and  examinations of whether the previously reported positive association between percentage of 
African ancestry informative genetic markers and risk of triple negative breast cancer may be 
due to gene-environment correlation rather than ancestral genotype. Each of these research 
approaches are geared toward elucidating whether the association between breast cancer subtype 
and 1) putative risk-increasing SNPs,  and/or 2) African genetic ancestry may be indirect, driven 
by the correlation between the phenotype of African ancestry – i.e., skin color – and socially 
patterned elements of the environment – i.e., race-related stress.  
Through such structurally mindful research programs, the nascent field of social 
genomics may help unpack the multifaceted relationship between not only race/ethnicity and 
breast cancer subtype, but perhaps also other persistent racial/ethnic health disparities in the 
United States.  Ultimately, results from these types of studies could be used to help identify 
policy or community actions to that address structural inequalities that contribute to worse health 
outcomes for racial/ethnic minority populations.  
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